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 SUMMARY 
Epidemiological studies and experiments in rodent embryos revealed that there is an 
increased risk for fetal malformations and spontaneous abortions in diabetic 
pregnancy. Diabetic embryopathy is a complication of maternal diabetes in which the 
embryo from a diabetic pregnancy develops congenital malformations in various 
organ systems, including cardiovascular, gastrointestinal, genitourinary, and nervous 
systems, among which the neural tube defects were frequently demonstrated. Though 
details of disease pathogenesis are complex, recent studies have demonstrated that 
altered expression of developmental control genes contribute to the neural tube 
defects (NTD) in embryos of diabetic mice.  
The neural tube patterning occurs early concomitantly with the neural 
induction. Since the neural tube has been shown to be derived from NSCs, which are 
self-renewing, multipotent progenitors, giving rise to different cell types such as 
neurons, astrocytes and oligodendrocytes that compose the nervous system, it is 
possible that maternal diabetes influences the proliferation and differentiation of 
NSCs leading to alteration of the lineage specification that determines the size, shape 
and histogenesis of the neural tube. Hence it was hypothesized that maternal diabetes 
alters the expression of some developmental control genes leading to abnormal 
proliferation and cell fate choice of NSCs, thereby resulting in patterning defect 
during the neural tube development. In order to address this, the present author has 
investigated the effect of high concentrations of glucose on the growth, survival, 
proliferation and cell-fate specification of NSCs isolated from the telencephalon of 
embryonic mice, and on the expression of some developmental control genes such as 
 xvi
 sonic hedgehog (Shh), bone morphogenetic protein 4 (Bmp4), neurogenin 1/2 
(Neurog1/2), achaete-scute complex-like 1 (Ascl1), oligodendrocyte transcription 
factor 1 (Olig1), oligodendrocyte lineage transcription factor 2 (Olig2), hairy and 
enhancer of split 1/5 (Hes1/5) and delta-like 1 (Dll1) in NSCs and their differentiated 
progeny cells.  
In the present study, NSCs were exposed to media containing either 
physiological glucose concentration (PG, 5mmol/l) or high concentration of glucose 
(HG, 30 or 45mmol/l). Cell viability, proliferation index and apoptosis of NSCs and 
differentiated cells exposed to PG or HG medium were examined by the tetrazolium 
salt assay, 5-bromo-2’-deoxyuridine (BrdU) labeling, terminal deoxynucleotidyl 
transferase-mediated dUTP nick end labeling (TUNEL) and immunocytochemistry. 
Expression of developmental control genes including Neurog1, Neurog2, Ascl1, 
Olig1, Olig2, Hes1, Hes5 and Dll1 as well as Shh and Bmp4, were analyzed by the 
real time RT-PCR and in situ hybridization in NSCs and differentiated cells exposed 
to PG and HG medium. Proliferation index and neuronal specification in the forebrain 
of embryos at embryonic day 11.5 were examined histologically. High concentration 
of glucose was found to impair the survival and proliferation efficiency and promote 
precocious neuronal and glial differentiation from NSCs.  These changes were 
associated with the altered mRNA expression of genes involved in neurogenesis and 
gliogenesis, such as Shh, Bmp4, Neurog1/2, Ascl1, Hes1/5, Dll1 and Olig1.  
Further, it has been shown that the earliest response to high glucose challenge 
in many cell types including embryonic neural tissues is the induction of oxidative 
stress, which is one of the suggested key factors responsible for maternal diabetes-
 xvii
 induced congenital malformations, including NTD in embryos. However, the 
mechanisms by which maternal diabetes induces oxidative stress in NSCs during 
neurulation are not clear. The present study was aimed to investigate whether high 
glucose induces oxidative stress in NSCs, and the mechanism by which high glucose 
alters the growth and survival of NSCs in vitro.  
High glucose induced generation of reactive oxygen species which contributes 
to the oxidative stress in NSCs.  The mRNA expression of aldose reductase (AR), 
which catalyzes the glucose reduction through polyol pathway, was increased in 
NSCs exposed to HG medium. The mRNA and protein expression of glucose 
transporter 1 (Glut1) which regulates glucose uptake in NSCs was increased at early 
stage (24h) and became downregulated at late stage (72h) of exposure to HG medium. 
Inhibition of AR by fidarestat, an AR inhibitor, decreased the oxidative stress, 
restored the cell viability and proliferation, and reduced apoptosis in NSCs exposed to 
HG medium. Moreover, inhibition of AR attenuated the downregulation of Glut1 
expression in NSCs exposed to HG medium for 72 hours. These results suggest that 
the activation of polyol pathway plays a role in the induction of oxidative stress which 
alters Glut1 expression and cell cycle progression in NSCs exposed to high glucose, 
thereby resulting in abnormal patterning of the neural tube in embryos of diabetic 
pregnancy. 
In conclusion, the present study demonstrates that high glucose medium alters 
the expression of genes that are involved in cell cycle progression and cell fate 
specification of the NSCs and differentiated cells leading to increased neuro- and glio-
genesis. In addition, high glucose alters the polyol pathway by inducing the 
 xviii
 expression of AR leading to intracellular metabolic disturbances and oxidative stress 
which could further contribute to altered expression of developmental control genes 
including Glut1, thereby resulting in abnormal viability and proliferation of NSCs. 
These changes are speculated to mimic the events that occur during the 
neurodevelopment in embryos of diabetic pregnancies, and may form the basis for 
defective neural tube patterning observed in embryos of diabetic women. 
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Chapter 1: Introduction 
 
1. General background of diabetes mellitus 
Diabetes mellitus (DM) represents a heterogeneous group of disorders that is 
characterized by absolute or relative deficiency of insulin secretion and/or insulin 
action, leading to abnormally high level of blood glucose, i.e. hyperglycemia (Bennett, 
1994). Diabetes mellitus is a major threat to global public health. In the year 2000, the 
prevalence of diabetes worldwide was estimated to be 2.8%, which were 
approximately 171 million people of all age groups. The number of people with 
diabetes is likely to increase to 366 million by 2030 due to population growth, aging, 
urbanization, and increasing prevalence of obesity and sedentary life style (Wild et al., 
2004).  
According to the criteria recommended by the National Diabetes Data Group 
(NDDG) in the United States and the World Health Organization (WHO)(1979; 1980; 
1985), diabetes mellitus can be divided into two major subgroups: Type I, or insulin-
dependent diabetes mellitus (IDDM) and Type II, or non-insulin-dependent diabetes 
mellitus (NIDDM). IDDM is associated with marked deficiency of insulin secretion 
which is due to an actual loss of β-cell mass. Approximately 5-10% of diabetics have 
IDDM which is common in children and young adults. In contrast, NIDDM is the 
consequence of a deficiency of insulin action due to abnormalities at the cell surface 
or within the cell. NIDDM patients have considerable preservation of the β-cell mass, 
which secretes sufficient quantities of insulin into the circulation. In addition to the 
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special group of diabetes mellitus which is recognized in females during pregnancy 
and usually disappears after pregnancy (Alberti and Zimmet, 1998; Bennett, 1994). 
1.1. Complications associated with diabetes mellitus 
Long-term diabetes mellitus can cause diverse complications such as retinopathy, 
nephropathy, macrovascular diseases, as well as neuropathy. Retinopathy is the most 
frequent complication of IDDM. After 14 years following diagnosis, almost all 
patients with IDDM developed retinopathy, manifested as microaneurysm and 
hemorrhage in the retina, with a cumulative incidence of 90% (Klein et al., 1984; 
Palmberg et al., 1981). The prevalence of retinopathy in patients with NIDDM rises 
from 5% among those with a duration of diabetes of less than 5 years to 30%, 45%, 
and 62% among those with a duration of diabetes of 5 to 9 years, 10 to 14 years, and 
15 or more years, respectively (Leibowitz et al., 1980). In individuals between 20 to 
74 years of age in industrialized countries, diabetes mellitus is one of the major causes 
leading to retinopathy and blindness (Lloyd et al., 1981). Moreover, diabetic 
nephropathy, a disorder affecting the function of kidney, manifested initially as a 
persistent elevation in urinary excretion of albumin and subsequently as an increase in 
excretion of protein, is often associated with the increased morbidity and mortality in 
individuals with diabetes (Mogenaen et al., 1983). In patients with IDDM, after a lag 
of 5 years following diabetes onset, risk of nephropathy rises rapidly, peaks during the 
second decade, and then declines (Krolewski et al., 1985). In contrast to IDDM, 
patients with NIDDM often have persistent proteinuria during the first 5 years of 
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NIDDM increases with age (Ballard et al., 1988). Among individuals with diabetes 
mellitus, the prevalence of macrovascular disease is also markedly increased. The 
major manifestations of macrovascular diseases are atherosclerosis of coronary 
arteries, cerebral arteries, and large arteries of the lower extremities. These 
macrovascular diseases are the major cause of mortality and significant morbidity in 
diabetic population (Pyorala et al., 1987). Furthermore, diabetes mellitus causes 
chronic, widely distributed lesions in the peripheral nerves, resulting in diabetic 
neuropathy. The most common form of diabetic neuropathy is a distal sensory 
polyneuropathy, with or without motor involvement, affecting fibers in a length-
related pattern, with longer fibers being more vulnerable (Thomas, 1984).  
1.2. Maternal diabetes and congenital malformation 
Diabetes mellitus in pregnancy is associated with congenital malformations in various 
developing organs in embryos. Maternal diabetes is estimated to complicate 2-6% of 
total pregnancies, depending on geographical and ethnic background. The frequency 
of maternal diabetes in 1998-2000  has been reported to be 1.7% in an African 
population (Ozumba et al., 2004), 4.1% among American Indian and white mothers, 
2.6% in Montana, and 3.2% in North Dakota and has increased significantly over the 
years (Moum et al., 2004; Lapolla et al., 2004). In Asia, the frequency of maternal 
diabetes is about 4-6% (Kieffer et al., 1999). 
The association between maternal diabetes and congenital malformations was 
suggested one hundred years ago (Mills and Withiam, 1986). Later, a series of  
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in infants of diabetic mothers (Day and Insley, 1976; Mills et al., 1979; Mills, 1982; 
Ramos-Arroyo et al., 1992; Aberg et al., 2001; Farrell et al., 2002; Sharpe et al., 2005; 
Sharpe et al., 2005). The incidence of congenital malformations among infants of 
diabetic mothers has been reported to range from 7.8% to 9.7%, while in infants of 
non-diabetic population it is approximately 2.1% in Washington State and Atlanta, 
US (Janssen et al., 1996; Becerra et al., 1990).  
Congenital malformations comprise both structural abnormalities which are 
recognizable by the naked eye, and functional abnormalities which have their origin 
in the perinatal period and are detrimental to the physical well-being of the newborn 
(Gabbe, 1977; Cowett and Schwartz, 1982). The functional abnormalities include 
disorders such as macrosomia, hypoglycemia, cardiomyopathy, and 
hyperbilirubinemia. On the other hand, the structural abnormalities associated with 
diabetic pregnancies include skeletal abnormalities such as sacral agenesis or absence 
of femur, genital abnormalities such as cryptorchidism and hypospadias, cardiac 
abnormalities such as ventricular septal defect and pulmonary artery stenosis, 
gastrointestinal tract abnormalities such as gastroschisis, as well as nervous system 
abnormalities (Amankwah et al., 1981). These defects are reported to arise during the 
period of organogenesis which in humans includes the first 8 weeks of gestation 
(Mills et al., 1979).  
1.3. Maternal diabetes-induced neural tube defects 
Among congenital malformations in infants of diabetic mothers, a variety of central 
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exencephaly, and spina bifida have  been reported (Becerra et al., 1990; Mills et al., 
1979). NTDs are caused when neural folds fail to elevate and fuse at the midline. In 
mouse, failure of closure of the rostral neural plate regions results in exencephaly (the 
equivalent of early stage of human anencephaly) (Harris and Juriloff, 1999). In this 
case, the brain development ceases and the vault of the skull fails to form. Failure of 
the caudal neuropore to close leads to spina bifida. The severity of this case depends 
on how much of the spinal cord is exposed. Neural tube closure defects including 
anencephaly and spina bifida are common birth defects in humans.  
The frequency of NTDs in infants of diabetic mothers is higher than that in 
non-diabetic women (Malins, 1978). In spite of improvement in the management of 
diabetic pregnancies in the past decades, congenital malformations including NTDs in 
infants of diabetic mothers remain two to three times higher than in the non-diabetic 
population (Reece and Hobbins, 1986; Phelan et al., 1997; Martinez-Frias, 1994). In 
recent years, several groups investigated the etiology of maternal diabetes-induced 
malformations including NTDs  (Loeken, 2005). However, the exact mechanism 
underlying maternal diabetes-induced NTDs is not clear yet.   
 
2. Molecular mechanisms of neural tube development  
2.1. Development of the neural tube  
In vertebrate embryos, three germ layers are formed during gastrulation: the 
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internally positioned neural tube, which forms the brain and spinal cord, (2) the 
externally positioned epidermis of the skin, and (3) the neural crest cells, which 
generate the peripheral neurons and glia, the pigment cells of the skin, and several 
other cell types (Gilbert, 2003). The neural tube is derived from a portion of ectoderm, 
which becomes thickened to form neuroectoderm. The process by which the flat layer 
of neuroectodermal cells is transformed into a hollow neural tube is called neurulation, 
and the embryo undergoing such changes is called the neurula.  
At the beginning of the process of neurulation, neuroectodermal cells receive 
signals from underlying mesoderm and elongate into columnar cells which form the 
prospective neural plate. The interaction between the neural plate and surrounding 
ectoderm promotes the shaping of neural plate, which lengthens along anterior-
posterior axis and bends subsequently to form a neural tube (Smith and Schoenwolf, 
1989). The bending of the neural plate involves the formation of hinge regions. The 
cells at the midline of the neural plate are called the medial hinge point (MHP) cells 
which are connected with the notochord beneath them and form a hinge. Shortly 
thereafter, two other hinge regions form near the connection of the neural plate with 
the lateral ectoderm. The cells of these two regions are called the dorsolateral hinge 
point (DLHP) cells. Each of the three hinges acts as a pivot to direct the rotation of 
the cells around it (Schoenwolf, 1991; Smith and Schoenwolf, 1989; Smith and 
Schoenwolf, 1991). MHP bending creates the ‘neural groove’, with a V-shaped cross 
section, while DLHP bending creates longitudinal furrows that bring the lateral 
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The neural tube closes as the paired neural folds elevate and their lateral edges 
move toward each other to contact and fuse at the dorsal midline. However, the 
number of initiation sites (where fusion of neural folds is initiated) of neural tube 
fusion and their location are still controversial (Sakai, 1989; Van Allen et al., 1993; 
Seller, 1995b; Seller, 1995a; Nakatsu et al., 2000; O'Rahilly and Muller, 2002). One 
hypothesis of “multiple sites of neural tube fusion”, which has been extensively 
studied in mice and rats, suggested that there are four initiation sites of rodent neural 
tube fusion that occur between day 8 and day 10 of gestation. The neural tube first 
fuses in the future cervical region between the third and fourth somites at the caudal 
part of the rhombencephalon, and progresses both caudally and rostrally (Illustration 
1a, site1). The second initiation site occurs at the prosencephalon-mesencephalon 
boundary and extends both caudally and rostrally (Illustration 1a, site 2). The third 
and fourth fusion sites appear at the rostral and caudal end of the neural plate, and 
extend caudally and rostrally respectively  (Illustration 1a, sites 3 and 4) (Sakai, 
1989)). Similarly, the multiple sites of neural tube fusion were proposed in human 
embryos. Van Allen and other authors postulated five initiation sites of fusion 
(Illustration 1b, sites 1-5) and the existence of a prosencephalic and a mesencephalic 
neuropore, in addition to the rostral and caudal neuropores (Seller, 1995b; Seller, 
1995a; Van Allen et al., 1993). In contrast, recently it has been suggested that there 
are 3 sites which include a major initiation site (Illustration 1c, site 1) and one or two 
apposition sites of neural tube fusion in human embryos (Illustration 1c, sites 2 and 3).  
Site 1 is the widely recognized fusion site located in the middle of future 
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One or two apposition sites are located at the rostral tip of the neural fold and/or the 
boundary between mesencephalon and rhombencephalon, which would be caught up 
by the fusion initiated from site 1 (Nakatsu et al., 2000; O'Rahilly and Muller, 2002). 
 
Illustration 1. Mechanisms of neural tube closure in mouse (a) and human (b, c). 
pros: prosencephalon; mes: mesencephalon; rh: rhomencephalon; 1-5: location of 
initiation sites of neural fold. (Detrait et al., 2005). 
2.2. Factors involved in neural tube development 
The developing neural tube is initially composed of neuroepithelium, a layer of 
rapidly dividing neural stem cells (NSCs) (Gilbert, 2003). NSCs are self-renewing, 
multipotent progenitors, giving rise to diverse types of neurons, astrocytes and 
oligodendrocytes that compose the nervous system. During the neural tube 
development, NSCs make three fundamental decisions. First, they make decisions 
about their positional identities within the neural tube. Secondly, they decide whether 
to self-renew or undergo mitotic arrest. Thirdly, they use inherited or externally 
derived information to direct their fate, either to become a more specified cell type or 
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neural tube depends on the accurate coordination of the proliferation, differentiation 
and apoptosis of NSCs. These events are mediated by a complex interplay between 
genetic and environment factors, which involve the action of inductive signaling 
molecules, secreted either from tissues other than the nervous system or from cells 
within the nervous system itself. Interpretation of these signals leads to the activation 
of transcription factors that control the cell number and the timing of differentiation of 
NSCs in specific positions. 
2.2.1. Morphogens 
During the neural tube development, the inductive signaling molecules involved in the 
regulation of the growth, patterning and morphogenetic movements of the neural tube 
are called morphogens (Cayuso and Marti, 2005; Monuki and Walsh, 2001). 
Morphogens are signaling molecules that are secreted from a restricted region of a 
tissue, spread away from their resources to form a concentration gradient, and specify 
distinct cell fates in a concentration-dependent manner (Teleman et al., 2001). 
Members of the fibroblast growth factor (FGF), wingless/Wnt (Wnt), hedgehog (Hh), 
and transforming growth factor β (TGF-β) families work as morphogens in specific 
contexts (Freeman and Gurdon, 2002). Among these morphogens, sonic hedgehog 
(SHH) and bone morphogenetic proteins (BMPs) regulate the positional and temporal 
specification of NSCs and the overall shape of the neural tube along the dorsal-ventral 
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2.2.1.1. Sonic hedgehog 
Sonic hedgehog (SHH), one of the members of the hedgehog family, is required for 
multiple aspects of development in a wide range of tissues including the nervous 
system (McMahon et al., 2003). SHH acts on target tissue by binding to its receptor 
Patched (Ptc), a 12-transmembrane protein (Marigo and Tabin, 1996). Binding of 
SHH to Ptc prevents the normal inhibition of smoothened (Smo), a seven-
transmembrane protein with a topology reminiscent of G-protein-coupled receptors, 
which is the signaling component of the SHH-receptor complex (van den and Ingham, 
1996). Finally, SHH signal is transduced via zinc-finger transcription factors of the 
Gli family (Altaba, 1998; Jacob and Briscoe, 2003).   
In the vertebrate nervous system, SHH signal is essential for patterning of the 
ventral neural tube. SHH is produced by two ventral midline signaling centers: the 
notochord, the axial mesoderm that underlies the ventral neural plate and the floor 
plate, a specialized population of cells at the ventral midline of the central nervous 
system (Marti et al., 1995). Progressive changes in SHH concentration generate signal 
gradient along ventral-dorsal axis of the neural tube, regulating the acquisition of 
distinct cell fates at defined positions (Briscoe and Ericson, 1999; Jessell, 2000).  
In addition to the fundamental role in patterning of the ventral neural tube, the 
SHH pathway has been demonstrated to play a role in the proliferation and survival of 
NSCs. Genetic manipulations, including the ectopic expression of SHH (Rowitch et 
al., 1999) or the ectopic activation of the SHH pathway by a constitutively activated 
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the removal of the Ptc1 activity (Goodrich et al., 1997), result in a dramatic 
hyperproliferative phenotype. Moreover, the phenotype of SHH mutant mice at early 
somite stages revealed that SHH is essential for the growth of both dorsal and ventral 
regions of the diencephalon and anterior midbrain regions (Britto et al., 2002; 
Ishibashi and McMahon, 2002). In addition, removal of notochord in chick embryos 
causes massive apoptosis and a decrease in size of the neural tube and this effect is 
suppressed by the application of exogenous SHH (Charrier et al., 2001). The anti-
apoptotic activity of SHH has been further demonstrated by the finding that 
overexpression of Ptc, in the absence of SHH, results in increased apoptosis in both 
cell cultures and neuroepithelium explant of chick. This apoptosis has been shown to 
be attenuated by the addition of SHH (Thibert et al., 2003). 
2.2.1.2. Bone morphogenetic proteins 
Bone morphogenetic proteins (BMPs) are members of the transforming growth factor 
β (TGF-β) super families. BMPs act through their receptors which are members from 
two families of receptor serine/threonine kinases, known as the type I and type II 
receptors. Binding of BMP ligands to Type II receptors activates type I receptors that 
in turn propagate the signal by phosphorylating the downstream transcription factors, 
Smad proteins (named by merging the names of the first identified members of this 
family: the C. elegans Sma protein and the Drosophila Mad protein). Phosphorylated 
Smad proteins translocate to the nucleus where they assemble complexes that control 
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BMPs were originally found to induce bone formation and hence they are 
known as bone morphogenetic proteins. However, they have been shown to regulate 
many other functions, i.e., cell division, apoptosis, cell migration, and differentiation 
(Hogan, 1996). During neurodevelopment in vertebrates, BMPs, especially BMP4 and 
BMP7, are involved in establishment of the dorsal fates of the neural tube.  Initially, 
BMP4 and BMP7 appear in the epidermis, which then establishes a second signaling 
center by inducing BMP4 expression in the roof plate cells of the neural tube (Liem, 
Jr. et al., 1995). The role of BMPs signaling in the dorsal patterning of the neural tube 
has been widely reported.  It has been reported that dorsal and intermediate neuronal 
cell types of the spinal cord in zebrafish embryos are established by BMP signaling 
pathway (Nguyen et al., 2000). Moreover, double knockout of BMP receptor type Ia 
(BMPRIa) and type Ib (BMPRIb) resulted in loss of dorsal neuron cell types in the 
developing spinal cord (Wine-Lee et al., 2004). 
Besides their role in the patterning of dorsal neural tube, BMPs also control 
cell survival and proliferation of neural precursors. Neural precursors cultured from 
cortical tissue of E13, E16 and perinatal rat brain respond to BMPs with apoptosis 
(E13), neurogenesis and gliogenesis (E16) and finally gliogenesis alone (perinatal) 
(Mehler et al., 2000). Furthermore, local application of BMP4 in embryonic forebrain 
explants of mice and overexpression of BMP4 in cultured sympathetic neuroblasts 
result in inhibition of proliferation and increase in apoptosis (Furuta et al., 1997; 
Gomes and Kessler, 2001). The differential response of neural precursors to BMPs 
signal may be due to the activation of different receptors of BMPs which have varied 
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proliferation in both transgenic mice and in cultured stem cells while overexpression 
of the BMPRIb induces mitotic arrest resulting initially in apoptosis and then in 
neuronal differentiation (Panchision et al., 2001).  
2.2.2. Notch signaling pathway 
Notch signaling pathway mediates cell-cell signaling between adjacent cells. Notch, a 
transmembrane protein, is activated by the ligands Delta and Jagged, which are also 
transmembrane proteins expressed by neighboring cells. Upon ligand binding, the 
intracellular domain of Notch (NICD) is released from the plasma membrane and 
translocates to the nucleus, where it binds to a transcription repressor CBF1 and 
converts CBF1 to a transcription activator, which induces the transcription of targets 
such as the Hes genes (Artavanis-Tsakonas et al., 1999; Iso et al., 2003; Kageyama 
and Ohtsuka, 1999). 
 The role of the Notch signaling pathway during neural development is best 
understood in Drosophila, where Notch inhibits differentiation by lateral signaling 
and regulates cell fate via inductive interactions. Notch1 mutant mouse embryos died 
during early embryogenesis (around embryonic day 11) (Swiatek et al., 1994), and the 
differentiation markers such as Math4A (also known as Neurog2), NeuroD (also 
known as Neurod2) and NSCL-1 (also known as Nhlh1) have been shown to be 
upregulated in mutants, indicating that Notch activity is required for progenitor 
maintenance (de la Pompa et al., 1997). In addition to receptor mutations, the Notch 
ligand mutations have also been examined in mice.  Deletion of Delta-like 1 (Dll1), 
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increase in neuronal markers such as  βIII-tubulin and GABA, supporting the view 
that Notch signaling inhibits neuronal differentiation in the developing central 
nervous system (Yun et al., 2002). The most widely studied Notch targets are the 
members of Hes family. Hes1-/- mutant embryos showed severe defects in neural 
development, including lack of cranial neural tube closure, and early expression of 
Mash1(also known as Ascl1),  a proneural gene, suggesting a precocious neurogenesis 
(Ishibashi et al., 1995). Similarly, precocious neurogenesis was evident in Hes5-/- 
mutants (Ohtsuka et al., 1999). In addition, Hes5-/- mutants showed a 30-40% 
decrease in number of Muller glial cells, supporting the role of Notch signaling in 
promoting glial fate (Gaiano and Fishell, 2002; Hojo et al., 2000).  
2.2.3. bHLH transcription factors 
The inductive signaling molecules direct cell activity by instructing the synthesis of 
different transcription factors, which establish the genetic network necessary for the 
development of the neural tube.  Several transcription factors with basic helix-loop-
helix (bHLH) motif have been reported to be implicated in the neurogenesis and 
gliogenesis by controlling the proliferation, specification, and differentiation of neural 
stem cells during development (Ross et al., 2003; Kageyama et al., 2005).  
2.2.3.1. Hes1 and Hes5 
The role of members of Hes (hairy and enhancer of split) family in neural 
development was first revealed in Drosophila in which the Hes homologs have been 
shown to negatively regulate neurogenesis (Knust et al., 1987). There are seven 
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the timing of differentiation in a variety of tissues, two of them in particular, Hes1 and 
Hes5, have been shown to have key roles in neural development (Ishibashi et al., 1995; 
Ohtsuka et al., 1999; Hatakeyama et al., 2004). Both Hes1 and Hes5 are expressed in 
the ventricular zone throughout the telencephalon where they maintain the neural 
progenitors in an undifferentiated, proliferative state and inhibit their differentiation 
into neurons (Akazawa et al., 1992; Ohtsuka et al., 2001).  
Hes factors have a conserved bHLH domain in the amino-terminal region and, 
through this domain, they form a dimer and bind to the DNA (Sasai et al., 1992). 
Studies to date have revealed that Hes proteins inhibit neuronal differentiation 
through two distinct mechanisms. First, Hes factors have a proline residue in the 
middle of the basic region and exhibit a higher binding affinity to the N box 
(CACNAG) than to the E box (CANNTG), unlike other bHLH factors, which bind to 
the E box with a higher affinity. Another structural feature is the carboxyl-terminal 
Trp-Arg-Pro-Trp sequence, the WRPW domain, which interacts with the corepressor 
TLE/Grg, a homolog of Drosophila Groucho, and recruits the histone deacetylase, 
thereby inactivating the chromatin and transcription of proneural genes, such as 
Mash1 (Grbavec and Stifani, 1996; Paroush et al., 1994; Chen et al., 1997). Second, 
Hes factors interact physically with proneural bHLH proteins, and this interaction 
functionally antagonizes the activity of proneural bHLH proteins. The proneural 
bHLH factors form a heterodimer with E-box-binding bHLH activator such as E47 
and promote neuronal differentiation. Hes1 forms a non-functional heterodimer with 




Chapter 1: Introduction 
 
Expression of Hes1 and Hes5 is regulated by Notch signaling (Ohtsuka et al., 
1999). Notch/Hes signaling may maintain a balance between the number of 
developing neurons and the number of remaining neural progenitors by a 
phenomenon known as lateral inhibition (Beatus and Lendahl, 1998). Newly formed 
neurons upregulate the Notch ligand, Delta, as they differentiate, and Delta activates 
Notch/Hes signaling in adjacent cells to block differentiation of progenitors. 
In addition, accumulating evidence suggests that Notch/Hes activity promotes 
astroglial formation. Overexpression of Hes1 causes the differentiation of progenitors 
derived from the spinal cord into astrocytes (Wu et al., 2003). In cultured adult 
hippocampal progenitors, Notch promotes astrocyte differentiation (Tanigaki et al., 
2001). Furthermore, the intracellular domain of Notch has been shown to directly 
activate the GFAP promoter (Ge et al., 2002). Thus, it is possible that an increase in 
Hes activity prior to the neurogenic phase may maintain precursors in an 
undifferentiated state, whereas an increase in Hes expression subsequent to the 
neurogenic phase may support astrocyte differentiation. 
2.2.3.2. Neurog1/2 and Ascl1  
Three proneural bHLH factors are known to be expressed in the mammalian 
developing nervous system: neurogenin 1, neurogenin 2 (Neurog1/2), and achaete-
scute complex-like 1 (Ascl1, also known as Mash1) (Guillemot and Joyner, 1993; Lo 
et al., 1991; Sommer et al., 1996). These bHLH factors are expressed at low levels 
while neural progenitors are being specified, and a transient increase in their 
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neurogenins are expressed in the dorsal part, which gives rise to glutamatergic 
neurons, whereas Ascl1 is predominantly expressed in the ventral part, which gives 
rise to GABAergic and cholinergic neurons, indicating different proneural bHLH 
factors involved in the specification of different neuronal subtypes (Wilson and 
Rubenstein, 2000). 
 In mouse, disruption of Ascl1 causes a loss of GABAergic interneurons in the 
cortex (Casarosa et al., 1999). When both Neurog2 and Ascl1 are absent, a failure of 
progenitor specification in both the ventral and dorsal telencephalon drastically 
reduces the number of cortical neurons (Fode et al., 2000). When neural progenitors 
from the Neurog2/Ascl1 double knockout mouse are cultured in vitro, they produce 
colonies containing significantly more astrocytes and fewer neurons (Nieto et al., 
2001). Collectively, these studies suggest that proneural bHLH genes are involved in 
the specification of cortical progenitors to a neuronal fate and that in their absence 
cortical progenitors become astrocytes instead. 
 A few studies have suggested that SHH and BMPs are involved in the 
regulation of proneural bHLH factors. For instance, Ascl1 has been shown to induce 
the specification of autonomic neurons from the neural crest (Guillemot et al., 1993). 
BMP2 and BMP4 also promote the differentiation of autonomic neurons and induce 
the expression of Ascl1 indicating that BMP2 and BMP4 control the specification of 
autonomic neurons through the induction of Ascl1 expression (Reissmann et al., 1996; 
Shah et al., 1996). In neural crest cell culture, SHH supports the differentiation of 
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involved in the specification of trigeminal sensory neurons through the induction of 
Neurog1 expression as Neurog1 has been shown to be required for the specification of 
trigeminal sensory neuron (Ota and Ito, 2003; Sommer et al., 1996).  
2.2.3.3. Olig1and Olig2 
Olig1 and Olig2 are the bHLH factors that regulate the specification of 
oligodendrocytes (Zhou et al., 2000; Lu et al., 2000). In the developing ventral 
telencephalon, Olig1 and Olig2 are expressed in the presumptive oligodendrocyte 
precursors and differentiated oligodendrocytes (Tekki-Kessaris et al., 2001). 
Disruption of both Olig1 and Olig2 causes the complete loss of the 
oligodendrocyte lineage throughout the CNS (Zhou and Anderson, 2002). Although 
oligodendrocyte development is completely inhibited in the spinal cord of Olig2 null 
mice,, early oligodendrocyte progenitors exist in the ventral forebrain, midbrain, 
cerebellum and medulla, suggesting that loss of Olig2 may be compensated by Olig1 
in the developing brain (Lu et al., 2002; Takebayashi et al., 2002).  
 Interestingly, Olig1/2 promotes not only the development of oligodendrocytes 
but also neurogenesis (Lu et al., 2002). In the developing spinal cord, the expression 
of Olig2 occurs in two waves, the first coinciding with the development of motor 
neurons, the second with the birth of oligodendrocytes (Lu et al., 2000; Takebayashi 
et al., 2000; Zhou et al., 2000). Disruption of Olig2 results in a loss of both motor 
neurons and oligodendrocytes (Lu et al., 2002). Thus, these findings suggest that 
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 In the forebrain, expression of Olig2 corresponds to regions of Shh expression, 
at the telencephalon-diencephalon border and adjacent to the floor plate in the 
diencephalon. Gain- and loss-of-function analyses in transgenic mice demonstrate that 
Shh is necessary for the expression of Olig genes, indicating that  SHH is also 
required for the specification of oligodendrocyte precursors (Alberta et al., 2001; Lu 
et al., 2000; Nery et al., 2001; Tekki-Kessaris et al., 2001).  
 
3. Hyperglycemia-associated molecular and cellular changes  
A complex coordination of extracellular signals and intrinsic factors play a significant 
role in regulating the development of the neural tube. These factors are possible 
targets that may be influenced by maternal diabetes, resulting in NTDs in infants of 
diabetic mothers.  
The association between hyperglycemia and risk of complications in patients 
with type 1 and type 2 diabetes mellitus has been studied by two large research groups. 
The Diabetes Control and Complications Trial (DCCT, USA) Research Group (1993) 
reported that intensive treatment with the goal of maintaining blood glucose 
concentrations close to the normal range effectively delays the onset and slows the 
progression of diabetic retinopathy, nephropathy, and neuropathy in patients with type 
1 diabetes mellitus. In addition, UK Prospective Diabetes Study (UKPDS) Group 
(1998) reported that intensive blood-glucose control with either sulphonylurea or 
insulin decreases the risk of microvascular complications in patients with type 2 
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indicate the importance of hyperglycemia in the pathogenesis of diabetic 
complications. In addition, hyperglycemia has been reported to cause adverse 
consequences, including changes in glucose metabolism, signal transduction, and 
cellular behaviors in several cell types, which are thought to be the basis of diabetic 
complications such as retinopathy, nephropathy, neuropathy and embryopathy 
(Brownlee, 2001; Loeken, 2005; Hiramatsu et al., 2002). 
3.1. Changes in cellular glucose uptake 
The fetal glucose concentration is directly related to maternal glucose concentration 
since the glucose used by the fetus is supplied by the mother (Hay, Jr. et al., 1984). 
The initial step for the glucose related metabolic pathway in many cell types is the 
basal glucose uptake which is regulated by the glucose transporter 1 (Glut1, also 
known as Slc2a1) (Vannucci et al., 1997a; Vannucci et al., 1997b). During the 
development, Glut1 expression is localized as early as the oocyte stage and 
subsequently in the neural tube, heart, gut, and optic vesicle in embryos (Matsumoto 
et al., 1995) and is regulated by glucose.  High concentration of glucose 
downregulates the expression of Glut1 which  is associated with increased oxidative 
stress in placental trophoblast cells (Ogura et al., 1999; Li et al., 2004). Maternal 
diabetes has also been shown to reduce Glut1 expression in preimplantation embryos, 
resulting in diabetic embryopathy (Moley et al., 1998b).  However, Glut1 expression 
was found to be upregulated in developing hearts of embryos derived from diabetic 
mice (Joyner and Smoak, 2004) indicating that Glut1 response to high glucose is 
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NSCs (Cai et al., 2004). However, little is known about the effect of high 
concentrations of glucose on the expression of Glut1 in NSCs that compose the neural 
tube during neurulation.  Since Glut1 is required for cell growth during development, 
it is hypothesized that high glucose alters the Glut1 expression and glucose uptake by 
NSCs, leading to abnormal proliferation of NSCs thereby resulting in abnormal 
development of the neural tube in embryos of diabetic pregnancy. 
3.2. Hyperglycemia-induced oxidative stress 
Intracellular oxidative stress is believed to play a central role in the pathogenesis of 
diabetic complications, including congenital malformation in various organ systems 
(Hockett et al., 2004; Niedowicz and Daleke, 2005). Free radicals such as reactive 
oxygen species (ROS), superoxide anion (O2.-) and hydroxyl radicals (.OH) are 
formed during a variety of biochemical reactions and cellular functions. The steady-
state formation of pro-oxidants (free radicals) is normally balanced by a similar rate 
of consumption by antioxidants. Oxidative stress results from an imbalance between 
formation and neutralization of pro-oxidants. Various pathologic processes disrupt 
this balance by increasing the formation of free radicals in proportion to the available 
antioxidants (thus, oxidative stress). Free radical formation and the effect of these 
toxic molecules on cell function are collectively called "oxidative stress." These free 
radicals react with (oxidize) various cellular components including DNA, proteins, 
lipids/fatty acids and advanced glycation end products (e.g. carbonyls). These 
reactions between cellular components and free radicals lead to DNA damage, 
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Hyperglycemia has been reported to cause oxidative stress by several 
mechanisms. Intracellular high glucose can undergo auto-oxidation via numerous 
intermediates to yield reactive glycation products, which can then react with proteins 
to generate advanced glycation end products (AGEs). Glycation products can bind 
cell surface receptors, which may perturb the activity of membrane NADPH oxidase, 
generate superoxide, and potentially cause cell damage (Wautier et al., 2001).Another 
well-described phenomenon is that high glucose causes interruption of the 
mitochondrial electron transport chain at complex III in the mitochondria of 
endothelial cells, resulting in increased oxidation of molecular oxygen by coenzyme 
Q and generation of superoxide anion (Brownlee, 2001).  
In addition, accumulating evidence indicates that elevated intracellular glucose 
concentration in many types of cell stimulates the expression of aldose reductase (AR, 
also known as Akr1b3), a widely expressed aldehyde metabolizing enzyme which 
catalyzes the reduction of glucose to sorbitol and galactitol through the polyol 
pathway using the nicotinamide adenine dinucleotide phosphate (NADPH). AR-
catalyzed reduction of glucose has been shown to be increased  significantly in high 
glucose environment (Gonzalez et al., 1984). 
Molecular approaches have provided evidence for the involvement of AR in 
diabetic complications. Selective transgenic overexpression of AR gene in the lens 
has been found to accelerate diabetic cataract formation in mice (Lee et al., 1995). 
Furthermore, treatment with pharmacological inhibitors of AR ameliorated 




Chapter 1: Introduction 
 
overexpression of the AR gene specifically in Schwann cells increased the rate of 
neuropathy in diabetic animals (Yagihashi et al., 2001) and caused severe motor nerve 
conduction velocity deficit under hyperglycemic stress (Song et al., 2003). 
  Although the exact mechanism by which AR contributes to the development 
of diabetic complications remains unclear, studies have indicated that the increase in 
the AR activity in hyperglycemic condition results in accumulation of polyols  in 
tissues, leading to osmotic pressure and oxidative stress (Bhatnagar and Srivastava, 
1992; Sheetz and King, 2002; Srivastava et al., 2005). Since AR utilizes NADPH to 
catalyze glucose reduction and NADPH is used for several critical reductive 
metabolic steps, the large consumption of NADPH in the hyperglycemic condition 
impairs the NADPH-dependent generation of reduced glutathione, an essential 
cellular antioxidant, and compromises the ability of the cell to protect itself from 
oxidative stress. These findings suggest that altered glucose metabolism through 
polyol pathway induces oxidative stress, which may be associated with the 
pathogenesis of diabetic complications such as retinopathy and neuropathy. However, 
no literature is available on the role of AR in the pathogenesis of congenital 
malformations including NTDs in infants of diabetic mothers.  
3.3. Alterations in signaling pathways 
The abnormal glucose metabolism and related biochemical changes in hyperglycemic 
conditions can alter various signaling pathways. One of the signaling pathways that 
are disturbed by hyperglycemia is the diacylglycerol-protein kinase C (DAG-PKC) 
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PKC contents have been demonstrated in many cell types or tissues, including retina, 
vascular cells, heart, and renal glomeruli of diabetic animal models and patients 
(Craven et al., 1990; Inoguchi et al., 1992; Ishii et al., 1996; Shiba et al., 1993). 
Besides the PKC pathway, activation of mitogen-activated protein (MAP) kinases 
pathway has been linked to the pathogenesis of diabetic complications including 
neuropathy (Tomlinson, 1999; Purves et al., 2001). All three MAP kinase families 
including p38, ERK and JNK were found to be activated in neurons of dorsal root 
ganglion (DRG) exposed to high glucose environment (Purves et al., 2001). Moreover, 
high glucose has been shown to induce DRG neuronal death which might be 
transduced via p38 and ERK pathways as the neuronal death was prevented by 
inhibitors of p38 and ERK MAP kinases (Purves and Tomlinson, 2002).  
Recently, maternal diabetes has been shown to induce NTDs which are 
associated with altered expression of several development control genes  required for 
neural tube development  (Phelan et al., 1997; Loeken, 2005; Liao et al., 2004; Fine et 
al., 1999). This indicates that the expression of some developmental genes which are 
involved in the formation of neural tube may be influenced by altered signaling 
pathways caused by hyperglycemia-induced metabolic changes. Hence, it is suggested 
that further studies are required to understand the effect of high glucose on the 
expression of some developmental genes encoding morphogens such as SHH and 
BMPs, Notch signaling molecules such as Dll1, and their downstream transcription 
factors, which are responsible for the regulation of growth, survival and 
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induced alteration in expression of genes that are implicated in the pathogenesis of 
NTDs. 
3.4. Cellular changes 
The metabolic changes and alteration in gene expression induced by hyperglycemia 
may further alter the cellular behaviors that ultimately lead to diabetic complications 
including congenital malformations in infants of diabetic mothers. A series of 
experimental studies demonstrate that hyperglycemia impairs cell proliferation and 
induces apoptosis during embryogenesis. It has been shown that high glucose inhibits 
the proliferation of first-trimester trophoblast cells in vitro (Weiss et al., 2001) and 
hyperglycemia alters cell cycle progression in the neural tube of embryos of diabetic 
mice (Chang et al., 2003). However, effects of high glucose on proliferation, 
apoptosis, as well as differentiation of NSCs have not yet been elucidated. In addition, 
it is not clear whether high glucose induces intracellular metabolic abnormalities in 
NSCs.  
 
4. Experimental models to study the pathogenesis of maternal diabetes-induced 
neural tube defects 
Multiple aspects of diabetes mellitus, including the pathogenesis, development of 
complications and their prevention, have been greatly facilitated by studies in 
experimental models. The study of high incidence of maternal diabetes-induced 




Chapter 1: Introduction 
 
dependent on animal models. Various animal models are available to study the 
diabetic complications. All animal models manifest hyperglycemia that mimics the 
symptoms of human disease and merit close attention. 
4.1 Diabetic animal models 
The animal models of diabetes can be classified, according to their clinical 
resemblance to human disease, into two types: animal models of insulin-dependent 
diabetes (IDDM) and non-insulin dependent diabetes (NIDDM). The animal models 
of IDDM can be induced by viral infection (Craighead, 1981), chemical destruction of 
pancreatic β-cells (Like and Rossini, 1976), partial pancreatectomy (Freyse et al., 
1982; Reiser et al., 1987), or immunologic mechanisms which inactivate insulin or 
destroy pancreatic islets (Toreson et al., 1968), resulting in destruction of islet β-cells 
that lead to an absence of intrinsic insulin secretion.  
Streptozotocin (STZ), an N-nitroso derivative of D-glucosamine, is one of the 
most commonly used chemical agents to produce animal models of IDDM (Rakieten 
et al., 1963). This agent has been shown to possess diabetogenic properties by causing 
selective destruction of pancreatic β-cells in many species (Junod et al., 1967; Like 
and Rossini, 1976; Ganda et al., 1976; Rossini et al., 1977). A single dose of 
intraperitoneal or intravenous injection of STZ (200-250 mg/kg body weight) causes 
hyperglycemia after 1-2h, followed by hypoglycemia from 6-12h after the injection, 
then by permanent hyperglycemia at approximately 24h. Islet β-cells necrosis is 
detectable by electron microscopic examination after 2 to 4 hours and by light 
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dose (40 mg/kg body weight) injection of STZ can induce diabetes in mice (Like and 
Rossini, 1976). Distortion of the islet architecture and β-cell necrosis is detectable by 
histological examination. Two to four weeks after the completion of injections, the 
remaining islets comprise exclusively of α- and δ- cells (Like and Rossini, 1976). It 
has been proposed that STZ breaks nuclear DNA strands of islet β-cell by generating 
free-radical oxygen (Yamamoto et al., 1981), and/or alkylates other key cellular 
enzymes necessary for the generation of adenosine triphosphate (ATP)(Wilson et al., 
1988), resulting in the decline in cellular nicotinatmide adenine dinucleotide (NAD). 
This eventually leads to islet β-cell death, and diabetes. 
The STZ-induced experimental diabetic animal models have been widely used 
for the study of teratogenic effects of maternal diabetes and possible mechanisms  of 
maternal  diabetes-induced congenital malformation (Giavini et al., 1986; Sakamaki et 
al., 1999; Hiramatsu et al., 2002; Cederberg et al., 2003; Liao et al., 2004; Wentzel et 
al., 2005). Four to five decades ago, studies of the maternal diabetes-induced 
congenital malformations using diabetic rodent models were carried out to establish 
the fact that the results of the animal experiments are relevant to the situation in 
human diabetic pregnancy. These studies described an increase in embryonic 
malformations and embryopathies in diabetic pregnancy in rodents (Bartelheimer and 
Kloos, 1952; Ross and Spector, 1952; Watanabe and Ingalls, 1963). Subsequent 
studies reported a wide range of congenital malformation and spontaneous abortions 
in diabetic pregnancies (Baker et al., 1981; Deuchar, 1977; Eriksson et al., 1983; 
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4.2. Neural stem cell (NSC) culture 
Recently, stem cell biology has emerged as a bridge between the traditional fields of 
cell biology and developmental genetics. In addition to their potential therapeutic role, 
stem cells can be exploited as experimental ‘logic chips’ that integrate information 
and exhibit self-organizing properties. NSCs are self-renewing, multipotent 
progenitors that give rise to the different types of neurons, astrocytes and 
oligodendrocytes that compose the nervous system (Gage, 2000). NSCs make three 
fundamental decisions during development. First, it determines its positional identity 
within the neural tube that has a dorsal-ventral, rostral-caudal and left-right axis. 
Secondly, it decides whether to self renew or undergo mitotic arrest. Thirdly, it 
interprets the mitotic arrest using inherited or externally derived information that 
directs it to a particular fate. These events occur sequentially during development and 
result in apoptosis, neurogenesis and then gliogenesis (Panchision et al., 2002). A 
complex orchestration of stem cell specification, expansion and differentiation is 
required for the proper development of the nervous system.        
NSCs assume the positional identity within the neural tube by the action of 
morphogens secreted from adjacent tissues. Positional identity along the 
anteroposterior axis is specified by FGF and Wnt family ligands whereas the 
dorsoventral axis is specified by the antagonistic actions of BMP/TGFß ligands and 
SHH (Altmann and Brivanlou, 2001; Freeman and Gurdon, 2002; Panchision and 
McKay, 2002). However, new environments and teratogenic factors may influence 
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influences major stem cell decisions that alter the size, shape and cellular diversity of 
the nervous system. It is proposed to examine the survival, proliferation and 
differentiation of individual stem cell colonies in high glucose environment as several 
genes that are involved in the process of lineage specification have been found to be 
altered in the developing brain of embryos from diabetic mice (Fine et al., 1999; Liao 
et al., 2004). 
NSC cultures can be prepared from the fetal or adult brain tissue in the areas 
that have been demonstrated to contain NSCs, such as, the subventricular zone (SVZ) 
or the hippocampus in the adult and a variety of regions in the developing brain(Gage, 
2000). The dissected tissues are dissociated into single cells and cultured in a specific 
culture medium supplemented with mitogens, such as epidermal growth factor (EGF) 
or fibroblast growth factor-2 (FGF-2) or both (Davis and Temple, 1994; Reynolds et 
al., 1992; Reynolds and Weiss, 1992). After some days of growth in vitro, NSCs 
aggregate into “neurospheres”. The identity of NSC can be demonstrated by anti-
nestin antibody. Nestin, a putative marker for NSCs, is an intermediate filament, 
which is first detected at the earliest stages in the neural plate. Majority of  the  cells 
in the neuroepithelium are nestin-positive before neurogenesis (Lendahl et al., 1990; 
Zimmerman et al., 1994). NSCs can be induced to differentiate into different lineages 
by withdrawing the mitogens such as EGF and bFGF from the culture medium. The 
cell fate specification of NSCs can be analyzed by staining with antibodies directed 
against antigens specific for neurons, astrocytes, and oligodendrocytes (Grandbarbe et 
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It is worth mentioning that the in vitro approach has its limitations. The cells 
have been removed from their natural environment and may lose their positional and 
temporal identity. In addition, the cells are exposed to non-physiological 
concentration of mitogens. In spite of the limitations, the in vitro NSC study may be 
the most direct and simple strategy for investigating the teratogenic effects of high 
glucose on the proliferation and cell fate specification of neural progenitor cells, and 
provides some clue which may be helpful to understand the mechanisms by which 
hyperglycemia influences major NSC decisions to regulate the size, shape and cellular 
diversity of the nervous system during development. Thus, the in vitro NSC culture 
could provide a useful experimental tool to understand the mechanisms of NTDs in 
infants of diabetic mothers.  
 
5. Specific Aims 
The aim of this study was to investigate the mechanism of the abnormal patterning of 
neural tube induced by maternal diabetes. Since NSCs determine size, shape and 
cellular diversity of the neural tube during the development, the cellular and 
molecular changes in NSCs exposed to both physiological and high concentration of 
glucose have been investigated. It has been previously shown that different cell 
cultures exposed to high glucose in vitro mimic the condition of hyperglycemia in 
vivo (Moley et al., 1998a; Ogura et al., 1999). It is hypothesized that high 
concentration of glucose in vitro alters several metabolic pathways and expression of 
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specification of NSCs. These changes may form the basis for the neural tube 
anomalies observed in embryos of diabetic pregnancy. 
First, the present author studied effects of high concentrations of glucose on 
the expression of genes involved in survival, proliferation, apoptosis, differentiation 
and cell fate specification of NSCs. These developmental control genes include 
morphogens such as Shh and Bmp4, ligand of Notch signaling pathway such as Dll1, 
and some basic helix-loop-helix transcription factors, such as Neurog1/2, Ascl1, 
Olig1/2, and Hes1/5. 
Secondly, the present author investigated the association between high 
glucose-induced intracellular metabolic changes and alterations in gene expression, 
growth and survival of NSCs. It has been shown that high concentration of glucose 
induces oxidative stress in various cell types by generating ROS. Oxidative stress, 
which is believed to play a major role in pathogenesis of diabetic complications, 
occurs by altered polyol metabolism. Accumulating evidence indicates that elevated 
intracellular glucose concentration in many cell types stimulates the expression of 
aldose reductase, a widely expressed aldehyde metabolizing enzyme which catalyzes 
the reduction of glucose to sorbitol and galactitol through the polyol pathway using 
the NADPH. Accumulation of sorbitol induces intracellular oxidative stress. It is 
hypothesized that high glucose impairs the expression of genes involved in cell cycle 
progression and cell fate specification of NSCs via intracellular metabolic changes, 
especially, oxidative stress caused by altered polyol metabolism. To address this, the 
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and mRNA expression of AR and Glut1, a glucose transporter in NSCs. The effect of 
fidarestat, an inhibitor of AR on ROS production and proliferation as well as 
apoptosis in NSCs exposed to high concentrations of glucose has also been 
investigated. This study would demonstrate whether oxidative stress has a pivotal role 
in causing adverse effects on the growth and survival of NSCs exposed to high 
glucose. This would also reveal possible therapeutic targets for the prevention and 
















Chapter 2: Materials and Methods 
1. Animals 
Swiss albino mice were used in the present study. The mice were purchased 
from the Laboratory Animal Centre (National University of Singapore, Singapore) 
and housed in clean cages with water and food ad libitum in a temperature-controlled 
room with 14 hours light and 10 hours dark schedule. Mouse embryos were obtained 
by mating male and female mice. Embryos collected from 15 diabetic (n=127) and 15 
normal (n=140) female mice were used for in vivo malformation analysis, 
immunohistochemistry and histological study. Embryos (n=240) from 30 female mice 
were used for neural stem cell cultures. The numbers of animals used in this study are 
listed in the Table 1. All procedures involving animal handling were in accordance 
with the guidelines of the Institutional Animal Care and Use Committee (IACUC), 
National University of Singapore. 
Table 1. Adult Swiss albino mice used in this study 
Age Sex Number Experiments 
8-10 weeks F 15 Diabetic pregnancy emale 
15 l pregnancy Norma
8-10 weeks F
30 Normal pregnancy for NSC culture 
emale 
Adult Male 20 Used for mating 
 
Table 2. Embryonic mice used in this study 
Age Number Experiments 
E13 2  normal pregnancy (n=30) N ures 40 from SC cult
121 from diabetic pregnancy (n=12) 
E11.5 
134 from normal pregnancy (n=12) 
Malformation analysis 
6 from diabetic pregnancy (n=3) 
E11.5 
6 from normal pregnancy (n=3) 
IHC, histology 
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In mouse, the neural tube is closed at embryonic day 9.5. Therefore, mouse 
embryos at E11.5 were used to distinguish the embryos with neural tube anomalies. In 
this study, NSCs were isolated from E13.5 norma e embryos since sufficient 
embryonic forebrain tissue can be obtained for NSC culture from embryos at this 
stage (Groszer et al., 2001). 
 




Streptozotocin (STZ) (Cat. No. S0130, Sigm h, USA) 
0.01M sodium citrate buffer: 
Deionised water 100ml 
a-Aldric
Sodium citrate  2.94g 
The pH was adjusted to 4.5 by adding 0.01mol/l citrate acid. 
2.2. Procedure 
Insulin-dependent diabetes mellitus was induced in 8-10 week-old female Swiss 
albino mice with an intraperitoneal injection of STZ (75mg/kg body weight) on three 
successive days under aseptic conditions. The STZ was freshly dissolved in 0.01M 
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3. Bloo
Procedure
d glucose test 
 
Blood glucose ouse was 
use-restrainer. The tip of the tail protruded out from the restrainer was 
punctured using a sharp sterile-blade. A drop of blood was placed on a blood glucose 
strip which was inserted into a blood glucometer (Glucometer Elite; Bayer 
HealthCare, USA) to measure the blood glucose. Only those mice with non-fasting 
blood glucose level exceeding 16mmol/l were used as experimental diabetic mice. 




 level was measured three days after STZ injection in mice. M
trapped in a mo
th
 
4. Collection of embry
4.1. Materi  
0.1M phosphate buffer (pH7.4): 
  NaH PO .H O   2.76g 
  Na HPO .2H O   14.24g 
Deionized H O was added to make up to 1 liter. The pH was adjusted 
to 7.4 with 1N hydrochloric acid (HCl) solution. 
4% paraformaldehyde (PF): 
Paraformaldehyde (Sigma)  4g 
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0.1M phosphate-buffered saline (PBS): 
Di-sodium hydrogen phosphate heptahydrate 13.3g 
Sodium chloride     8.5g 
Deionized H2O was added to make up to 1 liter. The pH was adjusted 
ic acid (HCl) solution. 




to 7.4 with 1N hydrochlor
0.1M phosphate buffer w 0% ose: 
  Sucrose     2
0.1M phosphate buffer (pH 7.4) 100ml 
 
Timed mating was carried out by placing three to five female mice with one normal 
male mouse in a cage overnight. Noon on the day on which a copulation plug was 
observed was counted as embryonic day 0.5 (E0.5) of pregnancy. Embryos were 
collected on E11.5 after Caesarean section of pregnant mice anaesthetized with 
pentobarbital (80mg/kg body weight, intraperitoneal injection). 
All fix
solution was p .1M phosphate buffer 
(pH 7.4 perature. The whole embryos were 
 sucrose in phosphate 
 were captured using a 
e (Nikon SMZ1500; Nikon, Japan) fitted with a camera. Embryos 
atives used were freshly prepared before use. The paraformaldehyde 
repared by heating paraformaldehyde powder in 0
). It was subsequently cooled to room tem
fixed in 4% PF at 4°C overnight and cryoprotected with 20%
buffer at 4°C for 4h. The images of whole embryos
stereomicroscop
with neural tube defects from diabetic mice and normal embryos from non-diabetic 
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5. Histology 
5.1. Materials           
1.5% gelatin solution: 
Distilled water  500ml 
Haematoxylin                        
unt 
Gelatin   7.5g 
Chrome Alum  0.75g 
Eosin 




Prepara s:tion of gelatinized slide  The slides were first cleansed by soaking in absolute 
alcohol for 2 m r-drie . Drie es were dipped in the gelatin solution for 1 
min and then d perature. Gelatinized slides were kept in a 37ºC oven 
for future use. 
Cryose
in and ai d d slid
ried at room tem
  
ctioning: Embryos with neural tube defects from diabetic mice and normal 
embryos from non-diabetic mice were mounted on a metal chuck using M-1 
embedding matrix (Lipshaw; Pittsburgh, USA) and rapidly frozen by quenching in 




Chapter 2: Materials and Methods 
CM 3050; Leica Microsystems, Germany). The sections were subsequently mounted 
lides and allowed to dry at room temperature for 2 hours.   
Haematoxylin and Eosin staining:
on gelatinized s
 For morphological studies, sections were stained 
washed in deionized water before counter-
 
6.1. Materials
with haematoxylin and eosin.  Frozen sections were rinsed in deionized water before 
staining with haematoxylin for 10 minutes at room temperature. Differentiation was 
achieved by dipping the mounted sections in acidified 70% ethanol (containing 
hydrochloric acid).  The sections were then 
staining with aqueous eosin for 5 minutes.  Finally, the sections were dehydrated in an 
ascending series of ethanol and passed through xylene before being mounted with 
Permount.  
6.  Primary culture of neural stem cells (NSCs) 
 
USA) 
Antibiotic antimycotic solution (Cat. No. A5955, Sigma-Aldrich, USA) 
Trypsin and EDTA (Cat. No. 15400-054, Invitrogen, USA) 
70µm nylon mesh (BD Biosciences, USA) 
Dulbecco's Modified Eagle Medium (DMEM) (Cat. No. 11966025, Invitrogen, 
F-12 Nutrient Mixture (F12) (Cat. No. 31765035, Invitrogen, USA) 
Insulin-Transferrin-Selenium (ITS) supplements (Cat. No. 51500056, 
Invitrogen, USA) 
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75cm2 tissue culture flasks (Nalge NUNC, Denmark) 
6.2. Procedure 
Embryos at E13.5 were collected after Caesarean section of pregnant mice 
anaesthetized with pentobarbital. Cerebral cortices were dissected out from embryos 
and mechanically dissociated in DMEM/F12 (1:1) containing 5mmol/l glucose. The 
cell suspension was filtered through a 70µm nylon mesh (BD Biosciences; USA), and 
cells were plated in 75cm  flasks (Nalge NUNC; Denmark) at a density of 5x104 
cells/cm  (Ben Hur et al., 1998; Grandbarbe et al., 2003). The serum-free DMEM/F12 
medium was supplemented with Insulin-Transferrin-Selenium supplements, EGF 
(20ng/ml) and antibiotic antimycotic solution. The cells were cultured at 37ºC in an 
incubator (ThermoForma; USA) with humidified atmosphere of 5%CO2 and 95% air. 




days in vitro, neurospheres were harvested by centrifugation, dissociated using trypsin 
and EDTA, and replated. After 3-4 days of growth, new neurospheres formed again, 
and second passage was performed. Cells were subcultured at least two times before 
subsequent experiments.  
7. Differentiation of NSCs 
7.1. Materials 
DMEM/F12 (1:1) (Invitrogen, USA)  
ITS supplements (Invitrogen, USA) 
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Fetal bovine serum (FBS) (Cat. No. 10099, Invitrogen, USA)  
0.01% poly-L-ornithine solution (Cat. No. P4957, Sigma-Aldrich, USA) 
0.1M phosphate-buffered saline (PBS) 
Round glass coverslips (13mm-in-diameter) 
24-well tissue culture plates 
lasks 25cm2 tissue culture f
7.2. Procedure 
Prepara lips:tion of Poly-L-ornithine-coated covers  NSCs were induced to differentiate 
in poly ell plates with poly-L-ornithine coated 
coversl m-in-diameter) were 
immers r for two times, 
air-drie ell of 
24-wel ded into each well of 24-well plates or 
25cm2 sels were incubated at 37ºC for 2 
hours, and washed with PBS for two times before use. 
Differentiation of NSCs was induced by transferring neurospheres to a 
differentiation medium containing DMEM/F12 (1:1), ITS supplements, antibiotic 
 
-L-ornithine coated flasks or 24-w
ips. Before coating, round glass coverslips (13m
ed in absolute alcohol overnight, washed with deionised wate
d, and finally autoclaved. Each sterile coverslip was placed into each w
l plate. Poly-L-ornithine solution was ad
flasks (0.5ml for 25cm2 of surface). The ves
antimycotic solution, and 2% of fetal bovine serum in poly-L-ornithine coated tissue 
culture vessels. The cultures were incubated in an incubator with humidified 
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8. Treatment of NSCs 
8.1. Materials 
D-glucose (Amresco, USA)    450.5mg 
DMEM/F12 (1:1)    10ml  
The solution was mixed thoroughly and filtered through a 0.2µm filter. 
1mM fidarestat stock solution: 
Fidarestat (Sanwa Kagaku Kenkyusho, Japan) 2.8mg 
Deionised water     10ml 
The solution was mixed thoroughly and filtered through a 0.2µm filter. 
255mM glucose stock solution: 
8.2. Procedure 
To study the effects of high concentration of glucose on the growth, survival, and 
differen ontrol group were incubated with medium 
containing physiolog
experimental g ol/l or 
45mmol/l) for appropr
aldose reductase and the high glucose-induced 
oxidative stres e inhibitor, was 
added to the m
 
 
tiation of NSCs, NSCs in c
ical concentration of glucose (PG, 5mmol/l), while NSCs in 
roups were exposed to high concentration of glucose (HG, 30mm
iate time courses. 
In order to study the activity of 
s in NSCs, 1µmol/l of fidarestat, an aldose reductas
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9. Analysis of cell viability 
9.1. Principle  
any); 2.  MTS based colorimetric assay kit 
(Promega, USA). Both XTT and MTS are yellow tetrazolium salts, which can be 
converted by the activity of cellular mitochondrial dehydrogenases into orange 
formazan products that are soluble in aqueous solutions. This conversion occurs only 
in metabolically active cells. The quantity of formazan products as measured at the 
90nm absorbance is directly proportional to the number of living cells in culture. The 
two cell viability kits have similar working principle. The only difference between 
them is that XTT reagent has to be mixed with electron coupling reagent before use.  
 To determine the number of viable cells in culture, cells are grown in a 96-
ure plate and incubated with the yellow XTT or MTS solution for 4 
Two cell viability kits were used in this study. They are: 1. XTT based colorimetric 
assay kit (Roche Applied Science, Germ
4
well tissue cult
hours. At the end of incubation, orange formazan solution is formed which can be 
quantified using a microplate reader (GENios, Tecan, Switzerland). An increase in 
number of living cells results in an increase in the overall activity of mitochondrial 
dehydrogenases in the sample. This increase directly correlates to the amount of 
orange formazan formed. 
9.2. Materials 
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CellTiter 96 Aqueous One Solution Cell Proliferation Assay kit (Cat. No. 
G3580, Promega, USA) 
9.3. Procedure 
5
To study the effects of high glucose on the viability of NSCs, dissociated NSCs were 
seeded in 96-well plates at a density of 3.5x10 /ml in 100µl of PG or HG (30mmol/l) 
medium per well. After 1 day or 3 days of incubation, cells were incubated for 
another 4h with addition of 50µl of the XTT labeling mixture (0.3mg/ml). 
90nm) was measured using a microplate reader (GENios, Tecan, 
Switzerland). To determine the viability of differentiated cells derived from NSCs, 
approximately 300 neurospheres grown in PG or HG (30mmol/l) medium for 3 days 
were transferred into each well of poly-L-ornithine coated 96-well plates with 100µl 
of PG or HG (30mmol/l) medium. XTT assays were performed after cells were 
induced to differentiate for 24h and 72h by the same method as described above. The 
absorbance is directly proportional to the number of NSCs or differentiated cells in 
The effects of aldose reductase inhibitor (fidarestat) on the viability of NSCs 
exposed to HG were examined using the MTS kit. The NSCs were cultured in 96-well 
plates in PG or HG (30mmol/l) medium with or without 1µmol/l of fidarestat for 24, 
48 or 72h. As instructed by manufacturer, 20µl of MTS reagent were added into each 
well containing cultures in 100µl of medium. The cultures were incubated for 4 h at 
Absorbance (4
each well at each time course. The relative increase of the number of cells was 
represented by the ratio of 72h absorbance to 24h absorbance. The results are 
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37ºC in a humidified atmosphere of 5% CO2 and 95% air before the absorbance at 
490nm was measured using a microplate reader (GENios, Tecan, Switzerland). The 
absorbance is directly proportional to the number of NSCs in each well at each time 
course. The relative increase of the number of NSCs in each of the four groups was 
represented by the ratio of 72h absorbance to 24h absorbance. The results are 
expressed as mean ± SD of the ratios. 
10. TUNEL analysis to detect apoptosis 
 
10.1. Principle  
Apoptosis is the most common form of cell death and is essential in many processes, 
including development of the various organs during embryogenesis. Inappropriate 
regulation of apoptosis may play an important role in many pathological conditions 
(Ceccatelli et al., 2004; Johnson, Jr. and Deckwerth, 1993; Oppenheim et al., 1999). 
In general, cells undergoing apoptosis display a characteristic pattern of structural 
changes in nucleus and cytoplasm, including rapid blebbing of plasma membrane and 
uclear disintegration. The nuclear collapse is associated with extensive damage to 
chromatin and cleavage of DNA into DNA fragments (Compton, 1992).  
Extensive DNA degradation is a characteristic event which often occurs in the 
early stages of apoptosis. Cleavage of genomic DNA during apoptosis may yield 
n
double-stranded, low molecular weight DNA fragments (mono- and 
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DNA. The DNA strand breaks can be identified by labeling the free 3’-OH termini 
with modified nucleotides in an enzymatic reaction. Terminal deoxynucleotidyl 
transferase (TdT) enzyme has been used for the incorporation of labeled nucleotides 
into DNA strand breaks in situ. This method which is described as TdT-mediated 
dUTP nick end labeling (TUNEL), is commonly used for detection of apoptosis 
(Gavrieli et al., 1992).  
10.2. Materials 
In situ cell death detection kit (Cat. No. 11684795910, Roche Applied Science,  
Germany) 
0.1M phosphate-buffered saline (PBS) 
0.1M PBS containing 0.1% Triton-X 100 (PBS-TX): 
Triton-X 100  1ml 
0.1MPBS  999ml 
4% paraformaldehyde (PF) 
4’, 6- diamidino-2-phenylindole dihydrochloride (DAPI) (Cat. No. D1306, 
Molecular Probes, USA) 
m iodide (PI) (Cat. No. P4170, Sigma-Aldrich, USA) 




Detection of apoptosis in NSCs and differentiated cells by TUNEL was performed 
with an in situ cell death detection kit according to the manufacturer’s instructions. 
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in 24-well pla p e courses, and washed twice with 
PBS. The cells were fixed with freshly prepared 4% PF for 1 hour at room 
temper ce. 
Subsequently, the cells were incubated with TUNEL reaction mixture containing the 
termina ides for 60 min 
at 37ºC with PI (5µg/ml) 
or DAPI (1µg/ml) for 5 min to stain the nuclei of all the cells, and mounted with 
Fluorescent Mounting Medium. The cells were viewed and images were captured 
 
11.1. Principle 
te and cultured for a propriate tim
ature, washed with PBS and incubated with PBS-TX for 2 min on i
l deoxynucleotidyl transferase and fluorescein-labeled nucleot
 in the dark. Finally, the cells were rinsed with PBS, incubated 
using a confocal microscope (Olympus FV1000, Olympus). TUNEL-positive 
apoptotic cells were counted and the data are presented as the percentage of TUNEL 
cells relative to the total number of cells.  
11. Analysis of proliferation index by BrdU labeling 
 
ling and disposal of radioisotopes and the 
necessity of expensive equipment.  
Evaluation of cell cycle progression is essential for investigations in many fields of 
biological sciences. Measurement of [3H] thymidine incorporation in cells that enter S 
phase during cell cycle has long been the traditional method for the detection of cell 
proliferation. Quantification of [3H] thymidine incorporation is performed by 
scintillation counting or autoradiography. This technology is slow, labor intensive and 




Chapter 2: Materials and Methods 
A well-established alternative to [3H] thymidine uptake has been demonstrated 
by numerous investigators(Gratzner, 1982; Lanier et al., 1989; Wynford-Thomas and 
Williams, 1986). Bromodeoxyuridine (BrdU), a thymidine analog, is incorporated 
11.2. Materials
into newly synthesized DNA strands of actively proliferating cells. Following partial 
denaturation of double stranded DNA, BrdU can be detected immunohistochemically 
using the anti-BrdU antibody. The proliferation index of the cells is analyzed by 
quantifying the percentage of BrdU positive cells.  
 
dU) (Cat. No. B5002, Sigma-Aldrich, USA) 
Mouse anti-BrdU monoclonal antibody (Cat. No. B2531, Sigma-Aldrich, USA) 
Rabbit anti- microtubule-associated protein 2 (MAP2) polyclonal antibody   
(Cat. No. AB5622, Chemicon, USA) 
FITC-conjugated goat anti-mouse IgG (Cat. No. AP124F, Chemicon,  USA) 
Cy3-conjugated goat anti-mouse IgG (Cat. No. AP124C, Chemicon, USA) 
FITC-conjugated goat anti-rabbit IgG (Cat. No. AP307C, Chemicon, USA) 
Mouse Ig blocking reagent (Cat. No. PK2200, Vector Laboratories, USA) 
4’, 6- diamidino-2-phenylindole dihydrochloride (DAPI, Molecular Probes) 
m iodide (PI, Sigma-Aldrich) 
5-bromo-2-deoxyuridine (Br
Propidiu
Fluorescent Mounting Medium (Dako) 
0.1M phosphate-buffered saline (PBS) 
0.1M PBS containing 0.1% Triton-X 100 (PBS-TX) 




Chapter 2: Materials and Methods 
11.3. Procedure 
In vitro proliferation analysis in NSCs: Neurospheres were transferred onto poly-L-
ornithine-coated coverslips in 24-well plates and incubated with BrdU (10µmol/l) for 
2h. For the analysis of proliferation index in differentiated cells, neurospheres were 
induced to differentiate for 3 days before they were incubated with BrdU (10µmol/l) 
for 2h. The cells were washed twice with PBS and fixed with 4% PF for 20 min at 4ºC. 
Subsequently cells were treated with 2N HCl at 37ºC for 30 min, washed with PBS 
for three times, blocked with 2% normal goat serum for 30 min, and incubated with 
anti-BrdU monoclonal antibody (1:1000) overnight at 4ºC. Further, the cells were 
washed with PBS, incubated with goat anti-mouse secondary antibody conjugated 
with FITC (1:200) for 1h at room temperature and counter-stained with PI (5µg/ml) 
In vivo analysis of cell proliferation in the telencephalon of E11.5 embryos: Pregnant 
mice from the control and diabetic groups (n=3 in each group) were injected 
intraperitoneally with BrdU (100mg/kg body weight) 2 hours before embryos were 
collected by Caesarean section. The whole embryos were fixed in 4% PF at 4°C 
overnight and cryoprotected with 20% sucrose in phosphate buffer at 4°C for 4h. 
Embryos with forebrain malformations from diabetic mice and normal embryos from 
non-diabetic mice were used as the experimental and control groups respectively. 
for counting the total cell number. The percentage of BrdU positive cells was 
determined by randomly scoring 20 neurospheres for each experimental and control 
groups in each independent experiment (n=5). The proliferation index is expressed as 
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Frontal sections of 20µm thickness through forebrain of the embryonic mouse were 
cut using a cryostat (Leica CM 3050, Leica Microsystems, Germany).  
sections were 
captured in a confocal microscope (Olympus FV1000, Olympus, Japan). For 
quantitative analysis, the number of BrdU-labeled cells in the dorsal, ventral and 
whole telencephalon was counted and the percentage calculated respectively. A total 
of six sections (two each from three embryos) from each group (normal and diabetic) 
were examined. Results are expressed as mean ± SD of the percentage of BrdU 
positive cells.  
Double immunofluorescence labeling was carried out for the localization of 
neurons and BrdU positive cells in tissue sections. Sections were rinsed in PBS, 
treated with 2mol/l HCl at 37ºC for 30 min, blocked with 5% normal goat serum and 
mouse Ig blocking reagent  for 1 hour, and incubated with mouse anti-BrdU 
monoclonal antibody (1:500) and rabbit anti-MAP2 polyclonal antibody (1:500) 
overnight at room temperature. Subsequently, sections were incubated with Cy3-
conjugated goat anti-mouse IgG (1:200) and FITC-conjugated goat anti-rabbit IgG 
(1:200) for 1 hour, counter-stained with DAPI (1µg/ml) and mounted with 
Fluorescent Mounting Medium. Finally, photo-images from the 
 
12. Fluorescent immunohistochemistry 
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Immunohistochemistry (IHC) combines anatomical, immunological and biochemical 
techniques for the localization of specific cellular components by means of a specific 
antigen/antibody reaction tagged with a visible label. The term immunohistochemistry 
is often used interchangeably with immunocytochemistry and immunostaining (Jones 
and Hartman, 1978). A series of technical developments in IHC has established 
sensitive detection systems, which are the enzyme-labeled system (for light 
labeled system (for electron microscope); 
ent dye-labeled system (for fluorescence microscope) (Giloh and 
Sedat, 1982; Johnson et al., 1982). 
antibody method, the primary antibody that has 
specificity against the antigen in question is added to the sample, followed by addition 
microscope); the electron-dense particles-
and the fluoresc
 The routine procedure for immunohistochemistry includes fixation, blocking, 
the incubation with primary antibody and the detection of first antibody. Fixation is 
required to stabilize the tissues or cells and protect them from the rigors of subsequent 
processing and staining techniques. Blocking of nonspecific background staining 
enhances the specificity of the primary antibody. Antibody molecules are labeled or 
flagged to permit their visualization. The detection system can be divided into direct 
conjugate-labeled antibody method and indirect conjugate-labeled antibody method. 
In the indirect conjugate-labeled 
of the labeled secondary antibody, which has specificity against an antigenic epitope 
present on the primary antibody. Thus, the secondary antibody serves to label the 
primary antibody, which, in turn, is bound to the antigen in tissue (Petrusz et al., 1980; 
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12.2. Materials 
Rabbit anti- MAP2 polyclonal antibody (Chemicon) 
Mouse anti- tubulin beta III isoform monoclonal antibody (Cat. No. AB1637, 
Chemicon, USA) 
Rabbit anti-chondroitin sulfate proteoglycan (NG2) polyclonal antibody (Cat. 
No. AB5320, Chemicon, USA) 
Rabbit anti-glial fibrillary acidic protein (GFAP) polyclonal antibody (Cat. No. 
AB5804, Chemicon, USA) 
nti-Nestin monoclonal antibody (Cat. No. MAB353, Chemicon, USA) 
Rabbit anti-Delta 1 polyclonal antibody (Cat. No. ab10554, Abcam, UK) 
Rabbit anti-Hes5 polyclonal antibody (Cat. No. AB5708, Chemicon, USA) 
Rabbit anti-Glut 1 polyclonal antibody (Cat. No. AB 1340, Chemicon, USA) 
FITC-conjugated goat anti-mouse IgG (Chemicon) 
Cy3-conjugated goat anti-mouse IgG (Chemicon) 
FITC-conjugated goat anti-rabbit IgG (Chemicon) 
Mouse Ig blocking reagent (Vector Laboratories) 
4’, 6- diamidino-2-phenylindole dihydrochloride (DAPI) (Molecular Probes) 
Fluorescent Mounting Medium (Dako) 
0.1M phosphate-buffered saline (PBS) 
0.1M PBS containing 0.1% Triton-X 100 (PBS-TX) 
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12.3. Procedure 
Neurospheres or differentiated cells exposed to different experimental conditions 
were transferred onto poly-L-ornithine coated coverslips in 24-well plate. For 
immunocytochemistry, the cells were fixed with 4% PF at 4ºC for 15 min, 
permeabilized with PBS-TX for 15 min, and blocked with 2.5% bovine serum 
albumin in PBS-TX for 30min. Cells were incubated with appropriate primary 
antibodies overnight at room temperature. Primary antibodies used were rabbit 
polyclonal anti-MAP2 (1:500) and mouse monoclonal anti-tubulin beta III isoform 
eurons, rabbit polyclonal anti-NG2 (1:300) for immature 
oligodendrocytes, rabbit polyclonal anti-GFAP (1:1000) for astrocytes, mouse 
monoclonal anti-Nestin (1:500) against the intermediate filament marker for neural 
precursor cells, rabbit polyclonal anti-Hes5 (1:200), rabbit polyclonal anti-Delta 1 
(1:100), and rabbit polyclonal anti-Glut1 (1:500). Subsequently, cells were washed 
with PBS and incubated with appropriate conjugated secondary antibodies (1:200, 
Chemicon, USA) for 1h at room temperature. Finally, cells were counterstained with 
DAPI (1µg/ml) for 5 min, and mounted with fluorescent mounting medium. The 
photo-images were captured using an Olympus BX51 fluorescent microscope or 
Olympus FV1000 confocal microscope. For the quantitative analysis of the cell fate 
specification of NSCs, the percentage of neurons, oligodendrocytes and astrocytes in 
relation to the total cell number was determined in 20 random fields under a 20X 
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13. Isolation of total RNA and Real time reverse transcription-polymerase chain 
reaction (RT-PCR) 
13.1. Principle  
annealing, and DNA synthesis, which are repeated for 30 or 40 cycles. During these 
steps, the double strand of the sample DNA melts open to become single stranded 
 
red to a specific region of single stranded sample DNA. The 3’ 
end of the primer serves as the starting point for the new DNA synthesis in the 
presence of DNA polymerase and nucleotides. Since the reaction mixture contains 
Reverse transcription combined with polymerase chain reaction (RT-PCR) has 
proven to be a powerful method to quantify the levels of mRNA expression (Murphy 
et al., 1990). The real time, fluorescence-based RT-PCR is a recent advance in 
quantitative RT-PCR technology which enables rapid and reproducible high 
throughput RT-PCR quantification, with extremely high sensitivity. Hence, real-time 
RT-PCR has become the method of choice for the quantification of gene expression 
(Bustin, 2000; Ginzinger, 2002). Real time RT-PCR incorporates a specific 
technology to detect the PCR product following each cycle of the reaction. This 
13.1.1. Polymerase chain reaction (PCR) is a technique used to amplify the number 
of copies of a specific region of DNA in order to produce enough DNA to be 
adequately tested. There are three basic steps in a PCR, including denaturation, 
DNA which is then hybridized with a set of 5’ and 3’ end primers, short fragments of
DNA that is base pai
primers complementary to both strands of sample DNA, the products of the DNA 
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technol
 Real time RT-PCR data analysis can be classified as absolute quantification or 
relative quantification. The absolute quantification involves the construction of a 
standard curve based on known copy numbers to determine the input copy number of 
the transcript of interest by relating the PCR signal to the standard curve, whereas the 
relative quantification involves determining the change in gene expression level 
relative to another set of experimental samples such as untreated controls or samples 
at time zero in a time-course study (Livak and Schmittgen, 2001). For most research 
applications, the relative quantification approach is more practical as it compares 
ogy involves a DNA-binding fluorescent dye, such as SYBR green I, which 
binds in the minor groove of double-stranded DNA (Morrison et al., 1998). When the 
DNA is denatured, the unbound dye emits little fluorescence in the reaction system. 
During extension, increasing amounts of dye bind to the newly formed double-
stranded DNA, resulting in an increase in the fluorescence signal. Thus, the 
fluorescence measurements performed at the end of the extension step of every PCR 
cycle reflect the increasing amount of amplified DNA. After a few cycles, the 
fluorescent signal is first recorded as statistically significant above background signal. 
This point is described as threshold cycle (Ct), which occurs during the exponential 
phase of amplification (Gibson et al., 1996). In addition, the specificity of the 
amplification and PCR product verification can be achieved by a melting curve of the 
PCR product (Ririe et al., 1997).  
experimental samples against controls directly. Furthermore, a normalization of the 
target gene with an endogenous reference gene is required for the relative 
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glyceraldehydes-3-phosphate dehydrogenase (G3PDH or GAPDH), albumin, actin, 
tubulin, cyclophilin, 18S rRNA or 28S rRNA are applicable as the reference genes 
(Marten et al., 1994; Thellin et al., 1999).  
-∆∆Ct
-∆∆Ct
13.1.2. Isolation of total RNA: The RNea
Using the 2  method (Livak and Schmittgen, 2001), the data are presented 
as the fold change of target gene expression normalized to an endogenous reference 
gene, relative to a calibrator. For the treated samples, evaluation of 2  indicates the 
fold change of gene expression relative to the untreated control. For this method to be 
valid, the amplification efficiencies of the target and reference must be approximately 
equal.  
sy technology (Qiagen, Germany) used in 
this study for RNA isolation combines the selective binding properties of a silica-gel-
based membrane with the speed of microspin technology. A specialized high-salt 
buffer system allows RNA longer than 200 bases to bind to the RNeasy silica-gel 
membrane. Cell or tissue samples are first lysed in the presence of a highly denaturing 
guanidine isothiocyanate (GITC)-containing buffer, which immediately inactivates 
RNases to ensure isolation of intact RNA. Ethanol is added to provide appropriate 
binding conditions, and the sample is then applied to an RNeasy mini column where 
the total RNA binds to the membrane and contaminants are efficiently washed away. 
High-quality RNA is then eluted in RNase-free water. With this RNeasy procedure, 
all RNA molecules longer than 200 nucleotides are isolated while most RNAs shorter 
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13.2. Materials 
RNeasy mini kit (Cat. No. 74106, Qiagen, Germany) 
Molony murine leukemia virus reverse transcriptase (M-MLV) (Cat. No. 
M1701, Promega, USA) 
Oligo(dT) primer (Cat. No. C1101, Promega, USA) 
dNTP mix (Cat. No. U1240, Promega, USA) 
RNase inhibitor (Cat. No. N2111, Promega, USA) 
LightCycler FastStart DNA MasterPLUS SYBR Green I (Cat. No. 03515885001, 





RNeasy e manufacturer’s instructions. Approximately, 5x106 
cells w ted by centrifugation and 
the cell For adherent differentiated cells, 
cells w d from the flask with a cell 
scraper
sample  column, centrifuged at 10,000g and the 
s discarded. The RNA bound to the membrane of column was 
washed with Buffer RW1 and RPE sequentially. Total RNA was then eluted in 25µl 
of RNase free water. The concentration and purity of the extracted RNA wa
evaluated spectrophotometrically at 260 and 280nm using a spectrophotometer 
(Eppendorf, Germany). 
Extraction of total RNA: Total RNA was extracted from the cells using the 
 mini kit according to th
ere used to extract the total RNA. NSCs were collec
 pellets were lysated in 350µl of Buffer RLT. 
ere lysated in 350µl of Buffer RLT and then scrape
. The lysate was homogenized and mixed with 350µl of 70% ethanol. The 
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13.3.2. cDNA synthesis: The synthesis of cDNA was carried out in a total volume of 
25µl reaction mix containing 2µg of RNA template, 2.5µmol/l Oligo(dT) primer, 
200U of M-MLV reverse transcriptase, 2mmol/l of each dNTPs, 5U of RNasin and 
RNase free water. First, 2µg of RNA with 1µl Oligo(dT) primer in a micro-centrifuge 
tube was heated to 70ºC  for 5min to melt secondary structure within the template. 
Subsequently, the tube was cooled on ice and other components were added and 
mixed gently. The reaction mix was incubated at 42ºC for 1 hour. Finally, the reaction 
was stopped by heating at 95ºC for 5min. The cDNA synthesized was store at 4ºC. 
13.3.4. Image of PCR products: The PCR products were run on 1% agarose gel with 
ethidium bromide by electrophoresis. The bands of PCR products in gel were 
 
13.3.3. The real-time RT-PCR: It was performed in a LightCycler instrument (Roche 
Applied Sciences) using 20µl of the reaction mix containing 5µl of cDNA, 4µl of  
LightCycler FastStart DNA MasterPLUS SYBR Green I master mix, 0.5µmol/l of each 
primer. Table2 presents the sequence and PCR conditions for each pair of primers 
used in this study. The PCR parameters were programmed according to the 
experimental protocol recommended by the manufacturer. 
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Table 3. Primers and reaction conditions for real time RT-PCR 





Gene Bank Product Annealing Extension e 
β-actin NM_007393.1 5’-tcacccacactgtgcccatctacga-3’ 5’-ggatgccacaggattccataccca-3’ 348 60/10 72/15 
Shh NM_009170.1 5’-ctggccagatgttttctggt-3’ 5’-gatgtcggggttgtaattgg-3’ 243 60/10 72/10 
Bmp4 NM_007554 5’-tgatacctgagaccgggaag-3’ 5’-agccggtaaagatccctcat-3’ 190 57/10 72/10 
Neurog1 NM_010896 5’-cgatccccttttctcctttc-3’ 5’-tgcagcaacctaacaagtgg-3’ 239 60/10 72/10 
Neurog2 NM_009718.2 5’-gctgtgggaatttcacctgt-3’ 5’-aaatttccacgcttgcattc-3’ 237 57/10 72/10 
Ascl1 M95603.1 5’-tcctgcttccaaagtccatt-3’ 482 57
5’-cgtcctctccggaactgat-3’ /10 72/20 
Olig1 BC046316.1 5’-cttgctctctccagccaaac-3’ 5’-gcgagcctgaaaaacagaac-3’ 214 60/10 72/10 
Ol 5’-ctggtgtcta c-3’ 5’-aggaggtgctggaggaagat-3’ 2ig2 NM_016967.1 
gtcgcccat 32 60/10 72/10 
Dll1 NM_07865.2 5’-ctgaggtgtaagatggaagcg-3’ 5’-caactgtccatagtgcaatgg-3’ 245 60/10 72/10 
Hes1 ’ NM_008235 5’-aaagacggcctctgagcaca-35’-tcatggcgttgatctgggtca-3’ 377 60/10 72/16 
Hes5 NM_010419 5’-aagtaccgtggcggtggagatgc-3’ 3’ 5’-cgctggaagtggtaaagcagctt- 354 60/10 72/15 
MAP2 NM_008632 5’-ctggacatcagcctcactca-3’ 5’-aataggtgccctgtgacctg-3’ 164 60/10 72/10 
Gfap NM_010277 5’-agaaaaccgcatcaccattc-3’ 5’-tcacatcaccacgtccttgt-3’ 184 60/10 72/10 
NG2 AF352400 5’-gcacgatgactctgagacca-3’  5’-agcatcgctgaaggctacat-3’ 223 60/10 72/10 
Nes NM_016701 5’-ttgaggcctccagaagaaga-3’ 5’-gccatctgctcctctttcac-3’ 173 60/10 72/10 
Akr1b3 NM_009658 5’-caagcctgaagatccgtctc-3’ 5’-caccctccagttcctgttgt-3’ 232 60/10 72/10 





Chapter 2: Materials and Methods 
14. In situ h
rinc
ybridization 
14.1. P iple 
In situ hybridization techn ucleic acid sequences to be detected 
lls or os ne exp on in ific ce s 
tissue g sp  al., 196 y la  seque f 
r R  pro ect pa lar se es of D r 
Bot e an e labe e com y used
tu hybridization. Initially, radioisotopes were used to label probes, and hybridized 
phy (John et al., 1969; Pardue and Gall, 
1969). However, there are several drawbacks in using radiolabeled probes, including 
me, rapid radioactive decay leading to a limited visualization window, 
ique allows specific n
in ce  tissue. It is p sible to localize the ge ressi  spec ll type
and regions usin ecific probes (John et 9). B beling nces o
DNA o NA, specific bes can be made to det rticu quenc NA o
RNA. h radioactiv d non-radioactive prob ls ar monl  for in 
si
sequences were detected by autoradiogra
long exposure ti
and the safety and disposal problems associated with radioactive material. Currently, 
labeled probes are prepared by incorporation of non-reactive digoxigenin (DIG)-
dUTP into nucleic acid. The labeled probes can be detected by anti-DIG IgG which is 
usually conjugated with alkaline phosphatase. In situ hybridization with DIG-labeled 
probes has been a widely used method to localize the expression of mRNA in tissue 
sections or cultured cells (Schaeren-Wiemers and Gerfin-Moser, 1993).  
14.2. Preparation of cRNA probes 
In order to prepare cRNA probes, plasmids containing cDNA of mouse sonic 
hedgehog (Shh), bone morphogenetic protein 4 (Bmp4) (gifts of Dr. L.M. Hogan), 
neurogenin 1/2 (Neurog1/2), achaete-scute complex-like 1 (Ascl1) (gifts of Dr. 
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lineage transcription factor 2 (Olig2), (Olig1, Olig2 are gifts of Dr. David J. Anderson) 
were amplified by E. coli transformation. 
14.3. Preparation of competent cells 
14.3.1. Materials 
TFB1 solution: 
RbCl2   1.2g 
MnCl2.4H2O  0.99g 
CaCl2   0.15g 
Glycerol  15.0g 
3M KAc  1ml 
The pH was adjusted to 5.8 by glacial acetic acid. The solution was 
h sterilized water. 
TFB2 solution: 
0.5M MOPS  2ml 
 0.12g 
OH. It was made up to 100ml with 
Luria-Bertani (LB) medium: 
made up to 100 ml wit
RbCl2  
CaCl2.2H2O  1.1g 
Glycerol  15.0 g 
The pH was adjusted to 6.8 with Na
sterilized water. 
Trypton  10g 
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NaCl   10g 
the NUMI store of the National 
14.3.2. Proced
H2O   1L 
LB medium was purchased from 
University of Singapore. 
ure 
XL Blue strain of E. coli was spread on the pre-warmed LB plate and incubated at 
37ºC overnight. The following day, a single clone was picked up and transferred into 
2.5ml LB medium, and shaken at 225rpm in an orbital shaker at 37ºC overnight. The 
overnight culture was transferred to 250ml LB at 37ºC, and shaken at 225rpm till the 
OD=0.6 (λ=600) was achieved. The cells were centrifuged at 4500g for 5 min at 4ºC. 
The pellet was re-suspended in 100ml of ice-cold TFB1 solution. The re-suspended 
cells were incubated on ice for 5min, and then spun at 4500g for 5min at 4ºC. The 
pellet was re-suspended in 10ml of TFB2 solution and incubated on ice for 30min. 
Finally the cells were dispensed 100µl/tube, rapidly immersed into liquid nitrogen, 
and stored in -80ºC freezer. 
14.4. Transformation of competent cells with plasmid 
14.4.1. Materials 
Plasmid mini kit (Cat. No. 12123, Qiagen, Germany) 
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14.4.2. Procedure 
5µl of plasmid (20ng/µl) was added into 100µl of competent cells and incubated on 
seconds and chilled on ice for 2 
min. Then, 900µl of LB was added into each tube, which was shaken in an orbital 
shaker (Forma, USA) at 200rpm, 37ºC for 1h. The cells were dispersed and spread 
evenly ated at 37ºC with the lid 
facing u ing down overnight. 
Five colonies were selected and each of them was transferred into a separate 
tube containing 5ml of LB with 100µg/ml Ampicillin, and the tubes were shaken at 
ernight. Cells from 2ml of E. coli culture were harvested and the 
   
by isopropanol precipitation. 
ice for 30 min. Cells were heat shocked at 42ºC for 90 
on LB plate (with Ampicillin, an antibiotic) and incub
p for a few minutes and then incubated with the lid fac
 
250rpm, 37 ºC ov
plasmids were extracted using a plasmid mini-prep commercial kit (Qiagen, 
Germany). The plasmid incorporation was confirmed with restriction enzyme analysis. 
 1ml of E. coli culture made from confirmed single colony was inoculated in a 
conical flask containing 100ml of LB with 100µg/ml Ampicillin and shaken at 
250rpm, 37ºC overnight. The cells were harvested and the recombinant plasmids were 
extracted using a plasmid midi kit (Qiagen, Germany). 
 According to the manufacturer’s instruction, the Qiagen plasmid purification 
technique is based on an alkaline lysis procedure, followed by binding of plasmid 
DNA to anion-exchange resin under appropriate low salt and pH conditions. RNA, 
proteins, dyes and low-molecular-weight impurities are removed by a medium-salt 
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14.5. Linearization of the plasmid 
14.5.1. Materials 
Tris-saturated phenol (pH 8.0) 
3M sodium acetate (pH 5.2) 
70% ethanol 
RNase free water 
14.5.2. Procedure
Restriction enzymes (Promega, USA) 
 
 specific restriction enzymes. Restriction digests were 
performed at 37ºC for 2 hours in a 100µl reaction containing 5µg of plasmid DNA 
with 25 Units of restriction enzyme and 1X buffer. Equal volume of Tris-saturated 
as added into the tube and mixed well. The tube was centrifuged at 
12000rpm for 10 min at 4ºC and the aqueous phase was transferred into a new tube. 
The DNA was precipitated with one tenth volume of 3M sodium acetate (pH 5.2) and 
2.5 volume of ethanol at -80ºC for 1 hour. After centrifugation at 10,000g for 15 min 
and washing the pellet with 70% ethanol, the linearized plasmid DNA was dried and 
dissolved in RNase free water. 
cription
Plasmids were linearized with
phenol (pH 8.0) w
14.6. In vitro trans  
14.6.1. Materials   
DIG RNA labeling mix (Cat. No. 1277073, Roche Applied Science, Germany)  
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1µg of , 1µl of 
T3/T7/ Nase-
free wa ix was incubated at 37ºC for 2hr (T3 and T7), or at 40ºC for 
3h (Sp6). At the end of incubation, 1µl of DNaseI was added and incubated at 37ºC 
for 15 m reaction was stopped with 2µl of 0.2M EDTA. cRNA fragments were 
precipitated with 1/10 volume of 4M LiCl and 2.5 volume of ethanol at -80ºC for 1 
hour. The precipitated cRNA was washed with 70% ethanol, dissolved in RNase-free 
water and stored at -80ºC. 
14.7. In situ hybridization using cell cultures
nscription reaction was performed in a 20µl volume of reaction mix containing 
linear DNA, 2µl of 10X Reaction buffer, 2µl of Dig RNA labeling mix
SP6 RNA polymerase, 1µl of RNase inhibitor, 0.2µl of 1M DTT, and R




DEPC treated Water: 
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DEPC  100µl 
Stirred overnight and autoclaved 
20X saline sodium citrate buffer (SSC): 
 NaCl  87.6g 
NaCitrate 44.1g 
DEPC-H2O was added up to 500ml and pH was adjusted to 4.5 with 
2N HCl.  
 
phate buffered saline with 0.2% BSA and 0.1% Triton X-100 (PBT): 
l 
BSA) 0.2g 







0.1M PBS    100m
Bovine serum albumin (
Triton X-100  
Stirred to mix thoroughly. 
10X Denhardt’s solution: 
Bovine serum albumin 
Polyvinylpyrrolidone   200m
Ficoll 400    200mg 
DEPC water was added up to 100m
H
Formamide    50ml 
20x SSC    25ml 
Yeast tRNA     50mg
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10x Denhardt’s solution  10ml 
  0.1ml 
 
Alkalin





  p to 0ml. 
Anti-di 4, Roche Applied 
Science
Nitro b 3-indoly phosphate (NBT/BCIP) 
at. No. 1681451, Roche Applied Science, Germany) 
14.7.2.
Tween 20  
0.5M EDTA    1ml 
DEPC water was added up to 100ml. 
e phosphatase (AP) buffer: 
1M Tris, pH9.5
1M MgCl2    0.5ml 
5M NaCl    0.2ml 
Tween 20    10µl 
125mM levamisole   40µl 
DEPC water was added u  1
goxygenin-AP, Fab fragments (Cat. No. 109327
, Germany) 
lue tetrazolium and 5-bromo-4-chloro-
(C
 Procedure 
Neurospheres and differentiated cells, cultured on Poly-L-ornithine coated coverslips 
in 24-well plates for an appropriate time course, were fixed with 4% 
paraformaldehyde and washed three times with PBS. The cultures were incubated in 
1x SSC for 5min,  permeabilized for 10min with 0.2M HCl and washed twice for 
5min in PBS. Pre-hybridization was performed at room temperature with 200µl of 
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by addi
at 85ºC to denature the probe and rapidly chilled on ice. The pre-hybridization buffer 
was rem
overnig 60ºC for 1 hour and at 
for 5 min. Subsequently, cultures were blocked in 5% sheep serum 
in PBT for 1 hour at room temperature and 0.001% sheep serum in PBT for 2 hours at 
room temperature, and washed three times with PBT for 10min each. For color 
reaction, the cultures were washed twice in AP buffer at room temperature for 10min 
each and incubated in NBT/BCIP (20µl/ ml of AP buffer) for 2-36 hours, depending 
on the abundance of the mRNA. The color reaction was stopped by washing with 
PBT and fixing in 4%PF. Cultures were mounted with 80% glycerol and visualized 
using a Light microscope (Olympus BX51, Japan). 
15. Estimation of reactive oxygen species (ROS) in NSCs 
ng 2µg DIG-labeled cRNA probe per ml hybridization buffer, heated for 5min 
oved and cultures were incubated with 100µl of hybridization mixture at 60ºC 
ht. The next day, cultures were washed in 0.2x SSC at 
room temperature 
 
15.1. Principle  
There are many methods for measuring free radical production in cells. 
Chemiluminescence of luminal (Mellqvist et al., 2000) and lucigenin (Gyllenhammar, 
1987), cytochrome c reduction (Dahlgren and Karlsson, 1999), ferrous oxidation of 
xylenol orange (Nourooz-Zadeh, 1999) and H DCF-DA (Carmody and Cotter, 2000) 
have been used successfully to detect ROS generation. Among these techniques, 
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H2DCF-DA, or 2’, 7’-dichlorodihydrofluorescein diacetate, is chemically 
reduced and acetylated form of 2’, 7’-dichlorofluorescein (DCF). H2DCF-DA is non-
fluorescent until the acetate group is removed by intracellular esterases. Activity of 
s cleaves H2DCF-DA into 2’, 7’-dichlorodydrofluorescein (H2DCF), 
-
H2DCFDA, a derivative of H
cellular esterase
which, in turn, is oxidized by ROS into fluorescent DCF. The oxidation can be 
detected by measuring the increase in fluorescence with a flow cytometer, using 
excitation sources and filters appropriate for fluorescein (FITC). This method is easy 
to use, extremely sensitive to changes in the redox state of a cell, inexpensive and can 
be used to follow changes in ROS over time.  
DCF is membrane permeable and can leak out of cells over time. CM
2DCF-DA with a thiol-reactive chloromethyl group, 
allows for covalent binding to intracellular components, permitting even longer 
retention of CM-DCF within the cell. In the present study, the ROS production in 
NSCs was detected by using CM-H2DCFDA  as an indicator (Chen et al., 2003; 
Obrosova et al., 2003).  
15.2. Materials 
CM-H DCFDA (Cat. No. C6827, Molecular Probes, USA) 




To examine the high glucose-induced oxidative stress in NSCs, cultures were divided 
into 5 groups: 1) NSCs in medium containing physiological concentration of glucose 
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glucose (HG, 30mmol/l) for 24h; 3) NSCs exposed to HG (30mmol/l) for 72 h; 4) 
NSCs exposed to HG (45mmol/l) for 24h; 5) NSCs exposed to HG (45mmol/l) for 
72h. At the end of the experiment, NSCs were collected by centrifugation and 
trypsinized into dissociated cells. The dissociated cells (1x106) of each group were re-
suspended in 0.5ml of pre-warmed PBS containing CM-H2DCFDA (10µmol/l) and 
incubat d recovered in pre-
warme as 
 flow cytometer with excitation at 488nm and emission at 535nm 
 
16. Western blot analysis 
ed for 30min in the dark at 37ºC. Cells were then washed an
d growth medium at 37ºC for 15min before the fluorescence in NSCs w
measured with a
(CyAn ADP, DakoCytomation, USA). The amount of ROS production was 
considered to be directly proportional to the fluorescence intensity. The fold changes 
of fluorescence intensity in NSCs of each group relative to the control were calculated. 
To examine the role of aldose reductase in the generation of ROS in NSCs 
exposed to high glucose, the NSCs were cultured for 72h in PG or HG (30mmol/l) 
medium with or without 1µmol/l of fidarestat (gift from Sanwa Kagaku Kenkyusho 
Co., Ltd., Nagoya, Japan), an aldose reductase inhibitor. It has been previously shown 
that 1µmol/l of fidarestat can block the total activity of aldose reductase (Obrosova et 
al., 2003). At the end of experiment, the amount of ROS generated by each of the four 
groups of NSCs was measured as described above. 
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Wester
 be nitrocellulose, polyvinylidene 
fluoride (PVDF) or nylon. Nitrocellulose and PVDF membranes are most commonly 
used for protein analysis. Primary antibodies are used to detect specific protein 
 Detection of antibody-antigen immune complexes on a 
g secondary antibodies covalently conjugated to 
horseradish peroxidase (HRP) enzyme. The chemiluminescence of HRP substrate is 
n blotting has become one of the most common protein analysis techniques 
used in biomedical research. Western blotting provides a direct method for identifying, 
monitoring, and determining the relative amount of specific proteins in different 
samples. The technique is fairly straightforward and can be performed quite rapidly. 
In general, a complex protein mixture (such as cell lysate or extract, or purified 
protein preparation) is fractionated on a gel by electrophoresis. After separation, 
proteins are transferred to a membrane, which can
antigens on the membrane.
membrane was accomplished usin
developed on standard X-ray film  
16.2. Materials 
Protease inhibitor cocktail kit (Cat. No. 78410, Pierce, USA) 
Mammalian protein extraction reagent (Cat. No. 78503, Pierce, USA) 
Protein assay kit (Cat. No. 5000002, Bio-Rad, USA) 
10% resolving gel: 
H2O    7.9ml 
  30% acrylamide mix  6.7ml 
1.5 M Tris (pH 8.8)  5.0ml 
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  10% ammonium persulfate 0.2ml 
  TEMED   0.008ml 
5% stacking gel: 
H2O    5.5ml 
 
 
 ium persulfate 0.08ml 
  
.8





 30% acrylamide mix  1.3ml 
1.0 M Tris (pH 6.8)  1.0ml 
 10% SDS   0.08ml 
 10% ammon
TEMED   0.008ml 
1x SDS gel-loading buffer: 
50mM Tris.Cl (pH 6 ) 
  100mM dithiothreitol 
  2% SDS 
  0.1% bromophenol blue 
glyce
ycine electrophoresis buffer: 
25mM Tris 
250mM glycine 
  0.1% SDS 
Transfer buffer: 
25mM Tris 
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1X TBS: 
  Tris base   2.42 g 
sted to pH 7.6 with 2N HCl 
  er 
nal antibody (Cat. No. AB1340, Chemicon, USA) 
gG conjugated with horseradish peroxidase (Cat. No. 7074, 
Cell Signaling Technology, USA) 
l antibody (Cat. No. A1978, Sigma-Aldrich, 
mouse IgG conjugated with horseradish peroxidase (Cat. No. 31430, 
  NaCl    0.8 g 
  H2O up to 1 liter; adju
1X TBST: 
1X TBS 1 lit
  0.1% Tween 20 
Rabbit anti-Glut1 polyclo
Goat anti-rabbit I





To analyze the effects of high concentration of glucose and fidarestat on the 
expression of Glut1 protein, NSCs were divided into 8 groups: 1) NSCs in PG 
medium for 72h, as the control; 2, 3, and 4) NSCs exposed to HG (30 mmol/l) 
medium for 24, 48, and 72 h, respectively; 5) NSCs in PG medium containing 1 
µmol/l of fidarestat; 6, 7, and 8) NSCs exposed to HG (30 mmol/l) medium with 1 
µmol/l of fidarestat for 24, 48, and 72 h, respectively. Protein extracts from these 
cultures were prepared using protein extraction reagent, which was supplemented 
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(3x106) as 
resuspended and lysed with 120µl of protein extraction reagent on ice for 10 min. The 
superna
at -20ºC for further use. 
The concentration of protein extracts was determined using a protein assay kit 
Aliquots of protein extracts (20 µg each) were heated to 100ºC for 3 min in 1x 
SDS gel-loading buffer to denature the proteins before the proteins were separated by 
10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE). Next, 
the proteins were transferred from the gel to the 0.2 µm PVDF membranes using a 
semi-dry electrophoretic transfer cell (Bio-Rad, USA). Membranes were washed with 
TBST 
 were pelleted by centrifugation at 2,500g for 5 min, and the pellet w
tant was collected by centrifugation at 14,000 g at 4ºC for 15 min and stored 
(Bio-Rad). Four different concentrations (0.06, 0.12, 0.24, and 0.48mg/ml) of bovine 
serum albumin (BSA) were prepared as protein standards. 10µl of each standard or 
sample and 200µl of dye reagent were added together to each well of a 96-well plate, 
and mixed thoroughly. The mixtures were incubated at room temperature for 10 min, 
and the absorbance at 595nm was measured using a microplate reader (GENios, 
Tecan, Switzerland). The concentration of protein extract was determined according 
to the standard curve of BSA. 
buffer and then blocked with 5% non-fat milk in TBST for 1 h at room 
temperature. Subsequently, the membranes were incubated with rabbit anti-Glut1 
antibody (1:1000) overnight at 4ºC in a shaker. The next day, blots were incubated 
with secondary anti-rabbit IgG antibody conjugated with horseradish peroxidase 
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by reprobing with anti- β-actin mAb (1:20000). Immunopositive bands were 
visualized by enhanced chemiluminescence (ECL), and quantified by scanning 
densitometer and Quantity One software, version 4.4.1 (Bio-Rad, USA). 
 
17. Statistical analysis 
The data of experiments were presented as mean ± SD. The standard deviation (SD) 






Where, x = individual observation, and n = number of observations 
Statistical analyses for various experiments performed in this study were 
carried out by Student’s t-test or one-way ANOVA using the Microsoft Excel and 
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1. Neural tube defects observed in embryos of diabetic mice 
About 12% (12.41%±3.54%) of embryos (E11.5) derived from diabetic pregnant mice 
(n=12) exhibited NTDs. In contrast, about 1% (1.15%±2.69%) of embryos (E11.5) 
derived from normal pregnant mice (n=12) xhibited NTD phenotype. The malformed 
embryos exhibited either exencephalic phenotype which is characterized by closure 
defect in the forebrain, midbrain and/or hindbrain, or spina bifida which is 
characterized by failure of closure of the caudal neural tube (Fig. 1a, b). 
The forebrain is a topographically complex structure that comprises the 
telencephalon and diencephalon. Frontal sections through the forebrain of E11.5 
embryos showed that both sides of the ne roepithelial wall were fused, thereby the 
size and volume of the telencephalic vesicles appeared to be reduced or absent in 
malformed embryos of diabetic mice compared to that of embryos from control group 
(Fig. 1c, d). In addition, the struct alon was found to be distorted as 
observed in some embryos of diabetic mice (Fig. 1c, d).  
 
2. High glucose disturbs the growth, survival, and cell fate specification of NSCs 
2.1. NSCs derived from mouse embryonic telencephalon in culture 
The neural stem cells (NSCs) derived from the telencephalon of mouse embryos (E13) 
were cultured in the serum-free medium containing epidermal growth factor (EGF). 
After a few cycles of cell divisions, NSCs grew into suspended aggregates, called 
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immunoreactivity (Fig. 2d-f), indicating that most of the cells in a neurosphere are 
neural progenitors. 
2.2. Vi
In order to investigate the effects of high concentration of glucose on the growth, 
survival, and proliferation of NSCs, NSCs were exposed to either physiological 
glucose concentration (PG, 5mmol/l) or high concentration of glucose (HG, 
30mmol/l). The viability of NSCs was examined by XTT assay. After three days of 
growth, the cell number in NSCs increased steadily. However, the relative increase in 
ell number of NSCs exposed to the HG medium was significantly less than that 
exposed to the PG medium (2.66±0.06 vs. 2.80±0.11 folds, p<0.05; Fig. 4a, b). It is 
not clear whether the decline in cell numbers is due to reduced proliferation or 
 The NSCs were induced to differentiate by withdrawing EGF (Fig. 3a-c). 
After 3 days of differentiation, NSCs gave rise to three cell types that compose the 
central nervous system, i.e. neurons, oligodendrocytes and astrocytes as demonstrated 
immunochemically using β-tubulin III, NG2 and GFAP antibodies respectively (Fig. 
3a-e). 
ability, apoptosis and proliferation of NSCs and differentiated cells in high 
glucose environment 
c
enhanced apoptosis in NSCs exposed to HG. 
To address this, BrdU incorporation and TUNEL assays were performed to 
analyze the proliferation index and apoptosis of NSCs respectively.  The percentage 
of BrdU positive cells was lower (29.68±8.03% vs. 41.72±4.76%, p<0.01; Fig. 5a-c), 
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5.04±0.75%, p<0.01; Fig. 6a-c) in NSCs exposed to the HG medium than those in the 
PG medium. These findings indicate that HG can influence the growth and survival of 
NSCs by inhibiting proliferation and enhancing apoptosis in NSCs. 
tiated cells exposed to the HG medium was similar to those cultured in the PG 
medium (Fig. 7a, b). After 3 days of differentiation, the proliferation index of 
differentiated cells from NSCs exposed to the HG medium appeared to be 
significantly decreased compared with those cultured in the PG medium (0.79±0.13% 
2.3. Cell fate specification of NSCs exposed to high glucose 
 
immunocytochemistry using antibodies against MAP2, NG2, and GFAP, which are 
markers for immature neurons, oligodendrocytes, and astrocytes respectively. After 3 
days of differentiation, all the three cell types were detectable in cultures exposed to 
either the PG or HG medium (Fig. 10a-f). However in cultures exposed to the HG 
 NSCs were grown in PG or HG medium for 3 days and then induced to 
differentiate by withdrawing EGF from the medium.  The viability of differentiated 
cells was measured after 1 and 3 days of differentiation. The relative increase of 
differen
vs. 1.10±0.11%, p<0.01; Fig. 8a-c). However, there was no significant difference in 
the number of apoptotic cells between the differentiated cells exposed to the PG and 
HG medium (Fig. 9). 
To determine whether HG influences the differentiation of NSCs, dissociated NSCs 
were cultured in PG or HG (30mmol/l) medium for 3 days and allowed to form 
neurospheres, which were subsequently induced to differentiate in the PG or HG 
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medium, the percentages of neurons, oligodendrocytes and astrocytes were higher 
than that in the PG medium (31.60±2.68% vs. 24.53±2.81%, p<0.05; 9.03±2.09% vs. 
5.54±1.74%, p<0.05; 44.79±1.76 vs. 35.10±4.70%, p<0.01, respectively; Fig. 10g), 
indicating that HG promotes differentiation of all the three cell types from NSCs. 
2.4. Cell proliferation and neuronal differentiation in the telencephalon of E11.5 
embryos of diabetic mice 
In order to determine whether the altered proliferation and differentiation observed in 
In addition to evidence based on phenotypes, results of quantitative real-time 
RT-PCR showed increased mRNA levels of Map2, Ng2, and Gfap (1.17±0.03, 
1.41±0.08, and 1.17±0.03 folds, p<0.01; respectively), and decreased mRNA level of 
Nestin (0.82±0.02 fold, p<0.01) in differentiated cells exposed to the HG medium (Fig. 
10h) compared to those exposed to the PG medium. It indicates that cultures exposed 
to HG have more differentiated cells and less NSCs than that in cultures exposed to 
PG medium.  
culture of NSCs exposed to HG medium mimic the events that occur during the 
neurodevelopment in embryos of diabetic pregnancies, we have investigated the 
proliferation index in the developing telencephalon of E11.5 embryos from diabetic 
and normal mice. Embryos with forebrain malformation from diabetic mice and 
normal embryos from non-diabetic mice were used as the experimental and control 
groups respectively. The frontal section of forebrain from the malformed embryos of 
diabetic mice was compared with that of embryos from controls (Fig. 11a-f). The 
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which was detected by immunostaining with anti-BrdU antibody. The percentage of 
BrdU labeled cells in relation to total cells in the neuroepithelium of telencephalon 
was considered as an index of cell proliferation in the neuroepithelium of developing 
telencephalon. Results of immunohistochemistry showed that the percentage of BrdU 
positive cells in the dorsal telencephalon of embryos from diabetic mice was 
significantly lower than that of embryos from controls (36.86±1.14% vs. 
54.32±2.28%, p<0.01; Fig. 11b, e and g). In the ventral telencephalon from embryos 
of diabetic mice,  the percentage of BrdU positive cells was significantly higher than 
that in embryos from normal mice (41.75±1.62% vs. 38.62±1.34%, p<0.05; Fig. 11c, 
f and g). However, the total percentage of BrdU positive cells in both dorsal and 
ventral telencephalon from embryos of diabetic mice was lower than that from 
embryos of controls (40.33±0.87% versus 43.34±1.48%, p<0.01; Fig. 11g). 
In addition, the neuronal differentiation in the telencephalon was examined by 
immunocytochemistry with antibody against neuronal marker, MAP2. Results of 
 
 
immunostaining also showed that there were more MAP2 positive neurons in the 
whole telencephalon of E11.5 embryos from diabetic mice in comparison to that of 
embryos from control (Fig. 11a-f). However, astrocytes and oligodendrocytes were 
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3. High glucose altered the expression of developmental control genes in NSCs 
and differentiated cells 
3.1. Morphogens 
3.1.1. Shh 
Since the developmental control genes that encode morphogens (e.g.  Shh and Bmp4), 
ligands of Notch signaling pathway (e.g. Dll1), as well as bHLH transcription factors 
(e.g. Neurog1/2, Ascl1, Olig1/2, and Hes1/5) are involved in the regulation of growth, 
survival, and differentiation of neuronal and non neuronal cell types from NSCs, 
effects of high concentration of glucose on the expression of these genes in NSCs and 
differentiated cells were examined. 
The mRNA expression of Shh (234bp) was detected both in NSC and differentiated 
cells (Fig. 12 a, b) and its expression leve
The mRNA expression of Shh in NSCs exposed to PG or HG medium for 3 
ays was analyzed by quantitative real-time RT-PCR. In NSCs exposed to the HG 
edium, the mRNA expression level of Shh (3.00±0.51 vs. 1.03±0.27 folds, p<0.01, 
Fig. 12d) was significantly increased in comparison with NSCs cultured in the PG 
medium.  
ls were quantified by real-time RT-PCR (Fig. 
12 c). The expression level of Shh mRNA in cells after 1-, 2-, and 3-day of 
differentiation from NSCs was increased significantly, compared to the mRNA level 
in NSCs (2.02±0.24 vs. 1.01±0.19, 3.36±0.45 vs. 1.01±0.19, 2.64±0.35 vs. 1.01±0.19 
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 Subsequently, the mRNA expression of Shh was quantified in differentiated 
cells. NSCs were induced to differentiate in either PG or HG medium for 3 days. The 
results of quantitative real-time RT-PCR revealed that the mRNA level of Shh was 
significantly increased in differentiated cells exposed to the HG medium, compared 
with those cultured in the PG medium (10.70±2.04 vs. 1.06±0.42 folds, p<0.01, Fig. 
12e).  
ization (Fig. 12f-i). In situ hybridization analysis 
has shown that the intensity of Shh mRNA expression appeared to be stronger in 
NSCs exposed to the HG medium than those in the PG medium (Fig. 12f, g). In situ 
n analysis provided further evidence that a higher number of 
The mRNA expression levels of Bmp4 (190bp) in NSC and differentiated cells were 
quantified by real-time RT-PCR (Fig. 13a-c). The mRNA expression levels of Bmp4 
in cells after 1-, 2-, and 3-days of differentiation from NSCs were significantly higher 
than th
The mRNA expression of Bmp4 in NSCs exposed to PG or HG medium for 3 
days was analyzed by quantitative real-time RT-PCR. In NSCs exposed to the HG 
medium, the mRNA expression level of Bmp4 was significantly increased in 
In addition, the mRNA expression of Shh was localized in NSCs and 
differentiated cells by in situ hybrid
hybridizatio
differentiated cells in cultures exposed to the HG medium exhibited mRNA 
expression of Shh than those in the PG medium (Fig. 12h, i).  
3.1.2. Bmp4 
at in NSCs (3.25±0.28 vs. 1.01±0.14, 11.50±3.88 vs. 1.01±0.14, 12.32±0.90 vs. 
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compar
The mRNA expression of Bmp4 was localized in NSCs and differentiated cells 
by in situ hybridization (Fig. 13e-h). The staining intensity of Bmp4 mRNA 
expression both in NSCs (Fig. 13e, f) and differentiated cells (Fig. 13g, h) exposed to 
PG an
3.2. Molecules of Notch signaling pathway 
e RT-PCR (Fig. 14a-
ession of Dll1 was significantly increased in cells after 1-day of 
differentiation, compared to that in NSCs (1.90±0.12 vs. 1.00±0.11 folds, p<0.01, Fig. 
14c). However, the expression level appeared to decline in cells after 2-3 days of 
differentiation to the expression level observed in NSCs. 
PCR. In NSCs exposed to the HG 
medium, the mRNA expression level of Dll1 was significantly decreased in 
comparison to that in NSCs exposed to the PG medium (0.81±0.05 vs. 1.00±0.03 
folds, p<0.01, Fig. 14d). On the other hand, the mRNA level of Dll1  was found to be 
ison with NSCs cultured in the PG medium (1.70±0.23 vs. 1.02±0.24 folds, 
p<0.01, Fig. 13d). However, mRNA expression level of Bmp4 in differentiated cells 
appeared to be unaltered by HG medium (data not shown). 
d HG medium appeared weak. No difference in staining intensity was 
detectable between cultures exposed to the PG and HG medium. 
3.2.1. Dll1 
The mRNA expression levels of Dll1 (245bp) in NSCs and in cells after 1-, 2-, and 3-
days of differentiation from NSCs were analyzed by the real-tim
c). The expr
 The mRNA expression of Dll1 in NSCs exposed to PG or HG medium was 
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increased significantly in the differentiated cells exposed to the HG medium, 
compared with that in cells exposed to the PG medium  (1.24±0.04 vs. 1.01±0.12 
folds, p<0.01, Fig. 14e). 
Expression of Dll1 protein was localized to the NSCs and cells after 3 days of 
differentiation by immunohistochemistry (Fig. 14f-i). The number of Dll1 positive 
cells was less in NSCs exposed to the HG medium than in NSCs exposed to the PG 
medium (Fig. 14f, g). In contrast, there were more Dll1-positive cells in differentiated 
cells exposed to the HG medium than that in the PG medium (Fig. 14h, i). 
 expression levels of Hes1 (377bp) in NSCs and in cells after 1-, 2-, and 3-
days of differentiation from NSCs were analyzed by real-time RT-PCR (Fig. 15a-c). 
The expression of Hes1 was downregulated significantly in cells after 1, 2, and 3-day 
of differentiation from NSCs in comparison to that in NSCs (0.68±0.03, 0.56±0.08, 
0.48±0.02 vs. 1.01±0.13 folds, respectively, p<0.01, Fig. 15c).  
expression level of Hes1  in 
NSCs exposed to the HG medium was significantly decreased in comparison with that 
in NSCs exposed to the PG medium(0.62±0.03 vs. 1.01±0.18 folds, p<0.01, Fig. 15d). 
However, the mRNA expression level of Hes1 in the differentiated cells was 
unaltered by HG medium. Immunoreactivity of Hes1 was not determined as the 
antibody purchased that targets Hes1 did not produce specific and reproducible results.  
3.2.2. Hes1 
The mRNA
The mRNA expression of Hes1 in NSCs exposed to PG or HG medium was 
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3.2.3. Hes5 
The mRNA expression levels of Hes5 (354bp) in NSCs and in cells after 1-, 2-, and 3-
days of differentiation from NSCs were analyzed by the real time RT-PCR (Fig. 16a-
c). The
 The quantitative real-time RT-PCR analysis showed that there was no 
significant difference in the mRNA expression level of Hes5 in NSCs exposed to PG 
Hes5 mRNA expression level in the 
differentiated cells exposed to the HG medium was found to be increased significantly, 
compared with the expression in cells exposed to the PG medium (2.25±0.27 vs. 
1.00±0.07 folds, p<0.01, Fig. 16d).  
s no difference in the 
number of Hes5-positive cells between NSCs exposed to the PG and HG medium (Fig. 
16e, f). In contrast, there were more Hes5-positive cells in differentiated cells exposed 
to the HG medium than that exposed to the PG medium (Fig. 16 g, h). 
3.3.1. Neurog1/2 
and 3-days of differentiation from NSCs were analyzed by real time RT-PCR (Fig. 
 mRNA expression of Hes5 was found to be upregulated in cells after 1 day of 
differentiation compared to that in NSCs (1.59±0.08 vs. 1.01±0.18 folds, p<0.01, Fig. 
16c).  
and HG medium (data not shown). However,  
Expression of Hes5 protein was localized to the NSCs and cells after 3 days of 
differentiation by immunohistochemistry (Fig. 16e-h). There wa
3.3. bHLH transcription factors 
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17a-c). The mRNA expression of Neurog1 in differentiated cells was upregulated 
after 1 and 2 days of differentiation (1.42±0.20 vs. 1.01±0.16 folds, p<0.05; 
3.19±0.61 vs. 1.01±0.16 folds, p<0.01) in comparison to that in NSCs (Fig. 17c).  
1 was significantly upregulated in NSCs exposed to the HG medium in 
comparison with that in NSCs exposed to PG medium (2.70±0.42 vs. 1.00±0.08 folds, 
p<0.01, Fig. 17d). In addition, the mRNA expression level of Neurog1  was found to 
be increased significantly in differentiated cells exposed to the HG medium, in 
comparison to that in cells exposed to the PG medium (5.52±0.61 vs. 1.00±0.08, 
p<0.01, Fig. 17e).  
sion of Neurog1 in NSCs and differentiated cells 
was detected by in situ hybridization (Fig. 17f-i). The intensity of Neurog1 mRNA 
expression appears to be stronger in differentiated cells (Fig. 17h, i) than in NSCs (Fig. 
17f, g).  In addition, a higher number of differentiated cells exposed to the HG 
medium (Fig. 17i) appears to exhibit mRNA expression of Neurog1 than those in the 
PG medium (Fig. 17h). 
In addition, the mRNA expression levels of Neurog2 (237bp) in NSCs and in 
cells after 1-, 2-, and 3-days of differentiation from NSCs were analyzed by the real 
ig. 18a-c). The mRNA expression levels of Neurog2 were 
The mRNA expression of Neurog1 in NSCs exposed to PG or HG medium 
was also analyzed by quantitative real time RT-PCR. The mRNA expression level of 
Neurog
Moreover, the mRNA expres
time RT-PCR (F
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(9.61±0.90 vs. 1.00±0.09 folds, p<0.01; 6.07±0.86 vs. 1.00±0.09 folds, p<0.01; 
5.51±0.65 vs. 1.00±0.09 folds, p<0.01, respectively; Fig. 18c).  
The mRNA expression of Neurog2 in NSCs exposed to PG or HG medium 
was als
The mRNA expression of this gene was localized in NSCs and differentiated 
cells by in situ hybridization (Fig. 18f-i). More number of cells appears to exhibit 
Neurog
3.3.2. Ascl 1 
levels of Ascl1 (482bp) in NSCs and in cells after 1-, 2-, and 
3-days of differentiation from NSCs were analyzed by real time RT-PCR (Fig. 19a-c). 
The mRNA expression of Ascl1 was decreased in differentiated cells after 3 days of 
culture, compared to the expression in NSCs (0.57±0.65 vs. 1.03±0.28 folds, p<0.05, 
Fig. 19c). 
o analyzed by quantitative real time RT-PCR. The mRNA expression level of 
Neurog2 (1.20±0.23 vs. 1.00±0.09 folds, p<0.05, Fig. 18d) was significantly 
upregulated in NSCs exposed to the HG medium in comparison with that in NSCs 
exposed to the PG medium. Similarly, expression of this gene was found to be 
increased significantly in differentiated cells exposed to the HG medium (2.31±0.76 
vs. 1.05±0.37 folds, p<0.01, Fig. 18e). 
2 mRNA expression in cultures of NSCs as well as differentiated cells 
exposed to the HG medium (Fig. 18g, i) than in those exposed to the PG medium (Fig. 
18f, h). 
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The mRNA expression of Ascl1 in NSCs exposed to PG or HG medium was 
also analyzed by the quantitative real time RT-PCR. The mRNA expression level of 
Ascl1 (1.34±0.26 vs. 1.05±0.35 folds, p<0.05, Fig. 19d) was significantly upregulated 
in NSCs exposed to the HG medium in comparison with that in NSCs exposed to PG 
medium. However, the mRNA expression of Ascl1 in differentiated cells appeared to 
be unaltered by the HG medium (data not shown).  
SCs exposed to the HG medium than in those 
exposed to the PG medium (Fig. 19e, f). However, there was no obvious change in the 
intensity of mRNA expression of Ascl1 in differentiated cells exposed to the HG 
medium in comparison to those exposed to PG medium (Fig. 19g, h).  
The mRNA expression levels of Olig1 (214bp) in NSCs and in cells after 1-, 2-, and 
erentiation from NSCs were analyzed by real time RT-PCR (Fig. 20a-c). 
The expression of Olig1 mRNA was significantly increased in cells 1-day after 
differentiation (1.66±0.33 vs. 1.01±0.19 folds, p<0.05) in comparison with that in 
NSCs (Fig. 20c). 
zed by quantitative real time RT-PCR. The mRNA expression level of 
Olig1 was significantly upregulated in NSCs exposed to the HG medium in 
comparison with that in NSCs exposed to PG medium (1.74±0.28 vs. 1.00±0.07 folds, 
The mRNA expression of Ascl1 was detected in NSCs and cells after 3-day of 
differentiation by in situ hybridization (Fig. 19e-h). The intensity of Ascl1 mRNA 
expression appeared to be stronger in N
3.3.3. Olig1/2 
3-days of diff
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p<0.01
In situ hybridization analysis showed that the intensity of Olig1 mRNA 
expression appeared to be stronger in NSCs exposed to the HG medium than in those 
exposed to the PG medium (Fig. 20e, f). However, mRNA expression of this gene in 
differentiated cells appeared to be unaltered by HG (Fig. 20g, h).  
In addition, the mRNA level of Olig2 was found to be upregulated in cells 
after 1 day (1.32±0.06 vs. 1.01±0.18 folds, p<0.05) and 2 days (1.43±0.26 vs. 
1.01±0.18 folds, p<0.05) of differentiation, in comparison to that in NSCs (Fig. 21a-c). 
The quantitative real time RT-PCR analysis showed that there were no significant 
differences in mRNA expression levels of Olig2 in NSCs as well as differentiated 
cells exposed to the PG and HG medium (data not shown). The results of in situ 
nalysis also revealed that there was no difference in the intensity of 
Olig2 mRNA expression in NSCs and differentiated cells exposed to the HG and PG 
medium (Fig. 21d-g). 
 their progeny. This alteration may be responsible for the changes 
in the growth, survival and differentiation of NSCs. In addition, it is worth noting that 
the expression of developmental genes in undifferentiated NSCs and differentiated 
cells respond differently to HG medium.  
, Fig. 20d). However, mRNA expression level of Olig1 in differentiated cells 
appeared to be unaltered by HG medium (data not shown).  
hybridization a
Collectively, these results indicate that HG disturbs the expression of 
developmental genes such as Shh, Bmp4, Neurog1/2, Ascl1, Olig1/2, Dll1, Hes1 and 
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4. High glucose induced oxidative stress in NSCs 
4.1. Generation of ROS in NSCs exposed to high glucose  
As oxidative stress has been shown to play a major role in the pathogenesis of 
diabetic complications, including congenital malformations associated with diabetic 
pregnancy (Hockett et al., 2004; Niedowicz and Daleke, 2005), HG-induced oxidative 
stress in NSCs was examined in this study by measuring the amount of intracellular 
ROS b
NSCs exposed to a medium containing 30mmol/l glucose for 
24h. Furthermore, NSCs exposed to 45mmol/l glucose for 72 h produced more ROS 
than those exposed to 30mmol/l glucose for 72 h (1.77±0.03 vs 1.40±0.03 folds, 
p<0.01). These results suggest that high glucose induces oxidative stress in NSCs in a 
time- and dose-dependent manner. 
The mRNA expression level of aldose reductase (AR, gene name: Akr1b3, 232bp) in 
SCs exposed to HG was quantified by real time RT-PCR (Figs. 23a, b). There was 
y flow cytometry using CM-H2DCFDA as the fluorescent probe. The 
fluorescence intensity detected was directly proportional to the amount of ROS 
generated in NSCs exposed to different glucose concentrations (Fig. 22a). The 
quantitative analysis of the relative fluorescence intensity in NSCs exposed to HG and 
PG medium revealed that NSCs exposed to the HG medium (30mmol/l glucose for 
72h and 45mmol/l glucose for 24h and 72h) generated more ROS (1.40±0.02 folds, 
p<0.01; 1.05±0.02 folds, p<0.05; 1.77±0.03, p<0.01; respectively), compared to NSCs 
exposed to the PG medium (Fig. 22b). However, there was no change in the amount 
of ROS production in 
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no significant difference in the mRNA expression level of AR between the two groups 
of NSC cultures exposed to the PG medium and the HG (30mmol/l) medium for 24 h. 
However, NSCs exposed to the HG medium for 72 h showed a significant increase in 
4.3. Effect of fidarestat on ROS production in NSCs exposed to different glucose 
concentrations 
4.4. Expression of Glut1 in NSCs was altered by high glucose and oxidative stress 
ed to various glucose concentrations for different 
time points by quantitative real time RT-PCR (Figs. 25a, b). The mRNA expression 
level of Glut1 was significantly higher in NSCs exposed to the HG (30mmol/l) 
the AR mRNA expression level compared with those cultured in the PG medium 
(1.21±0.03 vs 1.01±0.14 folds, p<0.01). 
To examine the role of AR in inducing oxidative stress in NSCs exposed to HG, 
1µmol/l of fidarestat, an AR inhibitor, was added to NSC cultures in either PG or HG 
(30mmol/l) medium. The changes in ROS production were determined in NSCs 
exposed to HG and PG medium by the relative CM-H2DCFDA fluorescence intensity 
(Fig. 24).  Fidarestat had no effect on the production of ROS in NSCs exposed to the 
PG medium, but had reduced the ROS production significantly in NSCs exposed to 
the HG medium by 47.4% (1.42±0.03 vs. 1.22±0.01 folds, p<0.01), indicating that AR 
has a role in inducing oxidative stress in NSCs exposed to HG.  
The expression levels of Glut1 (gene name: Slc2a1, 188bp) mRNA were quantified 
and compared among NSCs expos
medium for 24h than in NSCs exposed to the PG medium (1.26±0.08 vs 1.03±0.09 
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downregulated in NSCs exposed to the HG medium for 72h, compared to that in 
NSCs exposed to the PG medium (0.76±0.05 vs 1.03±0.09 folds, p<0.01; Fig. 25c). 
The present author also analyzed the protein expression of Glut1 in NSCs 
exposed to PG and HG media (30mmol/l) together with or without fidarestat for 
different time points by Western blot (Figs. 26a, b). The quantity of Glut1 expression 
g gene (Fig. 26a). The expression of Glut1 protein in NSCs exposed 
to the HG medium was significantly increased in 24h (1.57±0.05 folds, p<0.01) and 
gradually decreased to less than base level after 72h (0.82±0.02 folds, p<0.01), when 
compared to the expression of Glut1 in NSCs  exposed to the PG medium (Fig. 26b). 
This change in the Glut1 protein expression was consistent with the change in the 
Glut1 mRNA expression in NSCs exposed to HG.  
ion in NSCs exposed 
to the HG medium for 72h, when compared to that observed in NSCs exposed to HG 
without fidarestat (1.18±0.19 vs 0.82±0.02 folds, p<0.05, Fig. 26b). 
was normalized with the quantity of expression of β-actin protein which is the product 
of a house keepin
Inhibition of AR with fidarestat did not alter the upregulation of Glut1 protein 
expression in NSCs exposed to the HG medium for 24h. However,  fidarestat 
appeared to inhibit the downregulation of Glut1 protein express
Immunocytochemically, Glut1 was localized to NSCs exposed to the PG medium and 
the HG (30mmol/l) medium for 24h or 72h with or without fidarestat (Figs. 27a-i). 
The Glut1 expression was colocalized with Nestin which is a marker for neural stem 
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the HG medium for 24 h and decreased substantially after 72h (Figs. 27d-f). However, 
this decrease was not evident in NSCs treated with fidarestat (Figs. 27g-i). 
4.5. Ef
To examine whether HG-induced oxidative stress affects the viability of NSCs, the 
viability of NSCs exposed to PG or HG (30mmol/l) medium with or without fidarestat 
for 24, 48 or 72h was examined by MTS assay for different time courses (Fig. 28a). 
The fluorescent intensity detected by the MTS assay was considered to be directly 
proportional to the number of viable cells. The relative increase in the number of 
NSCs in each group was represented by the ratios of 72h viability to 24h viability (Fig. 
28b). The relative increase in number of NSCs exposed to the HG medium was less 
than that of NSCs exposed to the PG medium (1.63±0.04 vs 1.76±0.08 folds, p<0.01). 
Additio
Apoptosis in NSCs exposed to PG or HG (30mmol/l) with or without 
fidarestat was analyzed by TUNEL (Figs. 29a-d). The percentage of TUNEL positive 
cells in NSCs exposed to the HG medium for 72h was higher than that in NSCs 
exposed to the PG medium (14.41±2.26% vs. 5.36±2.17%, p<0.01; Fig. 29b, e). 
Addition of fidarestat significantly decreased the percentage of apoptotic cells in 
NSCs exposed to HG medium (6.33±3.10% vs. 14.41±2.26%, p<0.05; Fig. 29d, e).  
fects of fidarestat on viability, proliferation and apoptosis of NSCs exposed 
to high concentrations of glucose 
n of fidarestat restored the viability of NSCs exposed to HG as the relative 
increase in the number of NSCs exposed to the HG medium with fidarestat was higher 
in comparison to that of NSCs exposed to the HG medium without fidarestat (1.77 
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 Proliferation index of NSCs exposed to PG or HG (30mmol/l) media with or 
without fidarestat was measured by BrdU labeling and is presented as the percentage 
of BrdU positive cells in NSCs (Fig.30a-e). The percentage of BrdU positive cells in 
NSCs exposed to the HG medium for 72h was decreased when compared to that in 
NSCs exposed to the PG medium (26.13±3.53% vs 39.41±4.48%, p<0.01; Fig. 30b, e). 
Addition of fidarestat increased the proliferation index of NSCs exposed to the HG 
medium in comparison to that of NSCs exposed to the HG medium without fidarestat 
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Hyperglycemia is believed to be one of the critical factors that are associated with 
congenital malformations including NTDs in infants of diabetic mothers (Loeken, 
2005). It has been previously shown that maternal diabetes alters several 
developmental control genes that are involved in the patterning of neural tube in 
rodent embryos, leading to NTD (Liao et al., 2004; Pani et al., 2002; Phelan et al., 
1997). However, it is not clear whether maternal diabetes alters the expression of 
genes in NSCs or differentiated neuronal and glial cell types or in both during 
embryogenesis. Moreover, the complex nexus of high glucose-induced cellular 
metabolic disturbances with altered expression of developmental control genes, as 
well as abnormal proliferation and specification of NSCs is not well understood. A 
better understanding of these inf elp unravel the pathogenesis of 
NTDs in embryos of diabetic pre
In the present study, the author has characterized the viability, proliferation 
and specification of NSCs exposed to both physiological and high concentrations of 
lucose. It has been hypothesized that high concentration of glucose in vitro, which 
mimics the hyperglycemia in vivo, alters the intracellular metabolism and expression 
of developmental control genes in NSCs, leading to abnormal proliferation and 
specification, thereby resulting in defective neural tube patterning and subsequently 
NTDs. Hence, main aims of the present study were to investigate the effects of high 
concentration of glucose on the expression of some developmental control genes that 
are involved in viability, proliferation, and differentiation of NSCs, expression of 
Glut1 which mediates glucose uptake, expression and activity of aldose reductase, the 
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1. High glucose alters the expression of genes involved in proliferation and cell 
fate specification of embryonic NSCs  
It has been shown that maternal diabetes induces NTDs by altering the expression of 
various genes involved in the early neural tube patterning that occurs concomitantly 
with the neural induction from NSCs (Phelan et al., 1997; Fine et al., 1999; Temple, 
2001; Liao et al., 2004). The proliferation and differentiation of NSCs can be 
influenced by various maternal factors such as growth factors, cytokines and 
teratogens, leading to alteration of the cell fate choice that determines the size, shape 
and histogenesis of the neural tube (Hatakeyama et al., 2004; Qian et al., 2000; 
Temple, 2001). In the present study, high concentration of glucose in vitro impaired 
the survival and proliferation efficiency and accelerated the early differentiation of 
NSCs. These changes were associated with the altered expression of some 
develop
1.1. High glucose impairs the proliferation and survival of NSCs 
ing embryos in the 
mental control genes suggesting that NSCs are sensitive to glucotoxicity 
which may form the basis for the development of neural tube anomalies in embryos of 
diabetic pregnancy (Liao et al., 2004).  
A series of experimental studies revealed that high glucose impaired the cell 
proliferation in several types of tissues and cell lines. For instance, cell-cycle 
progression was shown to be decreased in human microvessel endothelial cells and 
mouse mesangial cells exposed to high glucose, leading to diabetic microvascular 
complications and nephropathy (Wolf et al., 2001; Abraham et al., 2003), . In addition, 
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first trimester of pregnancy (Pedersen and Molsted-Pedersen, 1981). In another report, 
the delay of placental and blastocyst growth in the poorly controlled diabetic 
pregnancy was correlated with decreased cell proliferation (De Hertogh et al., 1991; 
Weiss et al., 2001). In the present study, the proliferation index in the NSCs and 
differentiated cells exposed to high glucose in vitro was found to be decreased, 
indicating that changes in proliferation may impair the neurodevelopment as NSCs 
are required for the formation of different cell types in the neural tube. 
al telencephalic neuroepithelium is controlled 
by a distinct set of signaling molecules and transcription factors which may exhibit 
differential response to the glucotoxicity. To confirm this, the present author has 
It has been found from the present study that high glucose altered the 
expression of several genes, including Shh and Bmp4, that are involved in the cell 
cycle progression and apoptosis in NSCs and differentiated cells. BMPs play crucial 
However, the proliferation index in vivo differs from region to region in the 
neural tube of embryos from diabetic pregnancy as it may be influenced by locally 
expressed signaling molecules and transcription factors. The proliferation index 
appeared to be increased in the ventral telencephalon while it was obviously 
decreased in the dorsal telencephalon within the forebrain of embryos from diabetic 
pregnancy, suggesting that glucose-responsive local factors could influence the 
proliferation efficiency. This is possible as the forebrain morphology is complex and 
the development of its dorsal and ventr
analyzed the response of several developmental control genes in NSCs and 
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roles during regional morphogenesis of the dorsal telencephalon by promoting cell 
cycle arrest and inducing apoptosis in order to limit the growth of the neuroepithelium 
(Furuta et al., 1997). The proapoptotic and antiproliferative effects of Bmp4, one of 
the members of BMPs, on various cell types including ventricular zone progenitor 
cells and sympathetic neuroblasts have been well established (Glozak and Rogers, 
2001; Gomes and Kessler, 2001; Israsena and Kessler, 2002). Therefore, it is 
suggested that the high glucose-induced apoptosis and proliferation arrest in NSCs 
may be linked to the enhanced expression of Bmp4.  However in differentiated cells 
exposed to high glucose, Bmp4 mRNA expression appeared to be unaltered, 
indicating that the expression and effects of Bmp4 in response to maternal 
hyperglycemia during embryogenesis may vary depending on the location, 
developmental stage, cell types and its concentration as well as expression of other 
regulatory signaling molecules such as Shh (Furuta et al., 1997; Mabie et al., 1999; 
Israsena and Kessler, 2002; Liao et al., 2004).  
optosis (Thibert et al., 2003). Thus, it 
is possible that the increased expression of Shh in NSCs and differentiated cells 
exposed to high glucose could antagonize high glucose-mediated apoptosis and 
promote the survival of the NSCs and differentiated cells.   
Shh is a signaling molecule, secreted from the notochord and floor plate 
during early development in vertebrates. A ventrodorsal gradient expression of Shh in 
the neural tube directs the ventrodorsal patterning of the neural tube (Marti et al., 
1995). In addition, Shh has also been shown to promote the differentiation and 
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Overall, the disturbance in the normal cycle of cell death and proliferation of 
NSCs and their progenies in the developing neural tube by hyperglycemia may in turn 
contribute to the defective patterning and the subsequent complex neural tube 
anomalies in embryos of diabetic pregnancies. 
In addition to inducing cell cycle arrest and apoptosis in NSCs, high glucose also 
influences the lineage specification of NSCs, increasing the neurogenesis and 
gliogenesis (including astrocytes and oligodendrocytes) in the early stage of 
differentiation. Determination of neuron and glial cell fates from NSCs during neural 
tube development depends on the expression of signaling molecules such as Shh and 
BMPs and their downstream transcription factors such as bHLH factors (Vetter and 
Brown, 2001) and homeodomain factors (Jessell, 2000).  
Several lines of evidence suggest that S
1.2. High glucose promotes the neuronal and glial differentiation of NSCs. 
hh regulates the development of many 
neuron
ue to enhanced expression 
of Shh, leading to increased neurogenesis. Shh has also been shown to induce two 
al cell types and oligodendrocytes by activating the expression of members of 
bHLH factors such as Neurog1, Ascl1 and Olig1 (Alberta et al., 2001; Ota and Ito, 
2003; Ross et al., 2003; Tekki-Kessaris et al., 2001; Yung et al., 2002). During the 
neurodevelopment, the transient increase in the expression of Neurog1, Neurog2, and 
Ascl1 (the proneural bHLH factors) results in initiation of neurogenesis (Guillemot et 
al., 1993; Lo et al., 1991; Sommer et al., 1996). In the present study, the mRNA 
expression of Neurog1/2, and Ascl1 in NSCs and differentiated cells exposed to high 
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other b
lucose medium in this study appears to 
be the consequence of enhanced expression of Shh, contributing to increased 
specification of oligodendrocytes and motoneurons.  The unaltered expression of 
On the other hand, it has been found in the present study that two other bHLH 
factors, Hes1 and Hes5 which inhibit neurogenesis by maintaining progenitors in an 
undifferentiated proliferative state and by repressing proneural genes such as Ascl1 
and Ne
HLH transcription factors, Olig1 and Olig2 which promote sequential 
generation of motoneurons and oligodendrocytes (Lu et al., 2002; Nery et al., 2001; 
Tekki-Kessaris et al., 2001; Zhou and Anderson, 2002). Therefore, the increased 
expression of Olig1 in NSCs exposed to high g
Olig2 in NSCs exposed to high glucose medium reflects independent roles for Olig1 
and Olig2 during the neurodevelopment. It is suggested that the enhanced Shh 
expression in the NSCs is the basis for the induced specification of neurons and 
oligodendrocytes in the high glucose medium.  
urogenins (Bertrand et al., 2002), also responded to high glucose. Expression 
of these genes is regulated by the Notch/Delta signaling molecules which inhibit 
neuronal differentiation (Ohtsuka et al., 1999). The decreased mRNA expression of 
Dll1, a Notch ligand in NSCs exposed to high glucose could have caused 
downregulation of its downstream gene Hes1, resulting in accelerated neuronal 
differentiation, possibly by the unopposed action of its target gene Ascl1. In contrast, 
the mRNA expression of Dll1 and Hes5 in the differentiated cells exposed to high 
glucose medium was found to be increased, indicating that intrinsic differentiation 




Chapter 4: Discussion 
Moreover, a compensatory mechanism appears to be activated in the 
differentiating cells to promote astrocytogenesis which has been shown to be induced 
by Notch or Hes5 (Grandbarbe et al., 2003; Tanigaki et al., 2001). In the developing 
neural tube, astrocytes are generated from the dorsal domains where BMP signaling 
predominates (Briscoe and Ericson, 1999; Briscoe et al., 2000). BMPs are neurogenic 
during early stages and become gliogenic during late prenatal and early postnatal 
development.  Recently, Bmp4 has been shown to facilitate commitment of NSCs into 
astrocytes (Gomes et al., 2003; Liu et al., 2004), suggesting that the increased mRNA 
expression of GFAP and increased number of GFAP immuno-positive astrocytes 
amongst the differentiated cells exposed to high glucose medium may be mediated by 
the  enhanced expression of Bmp4. 
g embryogenesis (Chang 
et al., 2003). It is also possible that there could be a direct effect of high glucose on 
Although the precise mechanisms by which the elevated glucose level alters 
the expression of a distinct set of genes in NSCs and differentiated cells are not 
known at present, it is possible that high glucose could induce intracellular metabolic 
disturbances which may in turn lead to the observed changes in gene expression. In 
addition, oxidative stress mediated by glucotoxicity is considered to be the major 
contributing factor to the altered gene expression, as similar mechanism has been 
demonstrated in the inner cell mass of high glucose-treated mouse blastocysts 
(Leunda-Casi et al., 2002) and in endothelial cells exposed to high glucose medium 
(Zanetti et al., 2001). This has been further supported by the finding that 
hyperglycemia-induced oxidative stress inhibits the expression of Pax-3, a paired box 




Chapter 4: Discussion 
the exp
 
 expressed in the neural tube of rodent embryos 
during 
ression of some developmental genes, as in the process involved in regulation 
of glucose-responsive genes in the β-cell or the liver. 
2. Aldose reductase is implicated in high glucose-induced oxidative stress in 
NSCs 
Maternal hyperglycemia alters the glucose uptake and intracellular metabolism in 
many cell types during embryogenesis (Li et al., 2004; Moley et al., 1998b; Ogura et 
al., 1999) . Uptake of glucose into the cell is regulated by glucose transporters 
(Vannucci et al., 1997b).  There are several glucose transporter isoforms, among 
which Glut1 is the primary isoform
early organogenesis (Matsumoto et al., 1995). The expression of Glut1 can be 
regulated by glucose, as high concentration of glucose has been shown to decrease the 
expression of Glut1 in placental trophoblast cells  in vitro and in vivo (Ogura et al., 
1999). In the present study, the glucose uptake was regulated by Glut1 which 
exhibited differential expression in NSCs exposed to different concentrations of 
glucose. In addition, high concentration of glucose induced oxidative stress in NSCs 
in a time- and dose-dependent manner, as revealed by the increased production of 
ROS. This induction of oxidative stress was associated with altered polyol 
metabolism involving aldose reductase and impaired cell viability as well as cell 
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2.1. High glucose induces oxidative stress in NSCs via polyol pathway 
Induction of oxidative stress is one of the earliest responses to high glucose challenge 
 many cell types including embryonic and adult neural tissues (Yang et al., 1997; 
Chang et al., 2003; Vincent et al., 2004).  One of the mechanisms by which high 
glucose induced intracellular oxidative stress is the increase in glucose reduction by 
polyol pathway flux (Brownlee, 2001; Allen et al., 2005). Aldose reductase (AR) is 
Inhibition of AR by its inhibitor, fidarestat, could only partially attenuate the 
high glucose-induced oxidative stress in NSCs. This could be due to the fact that 
oxidative stress occurs in many cell types as a result of various metabolic disturbances 
in addition to increased polyol pathway flux. For instance, high concentration of 
glucose significantly increased the mitochondrial superoxide production in the retina 
r retinal Müller cells and bovine retinal endothelial cells and the activity of NADPH 
in
the rate limiting enzyme in the polyol pathway and catalyzes the reduction of 
intracellular glucose to sorbitol by using NADPH. The present study demonstrates 
that expression of AR was increased in NSCs exposed to high glucose, indicating an 
increased enzymatic reduction of glucose to sorbitol. Since AR utilizes NADPH to 
catalyze glucose reduction (Bhatnagar and Srivastava, 1992; Sheetz and King, 2002), 
the significant increase in the AR-catalyzed glucose reduction in NSCs exposed to 
high glucose indicates the increased utilization of NADPH. As NADPH is used for 
several critical reductive metabolic steps such as the detoxification of ROS and 
hydroperoxides, a significant drain on the NADPH could compromise the ability of 
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oxidase in several other cell types, including endothelial cells, vascular smooth 
muscle cells, and retinal mesangial cells, contributing to intracellular ROS generation 
and oxidative stress (Inoguchi et al., 2003; Li and Shah, 2003).  
Hyperglycemia-induced oxidative stress has been shown to inhibit the proliferation of 
endothelial cells (Zanetti et al., 2001) and increase the cell death in mouse blastocysts 
(Leunda-Casi et al., 2002). In the present study, exposure to high glucose (30mmol/l 
for 72h) decreased the viability and proliferation efficiency of NSCs and increased the 
apoptosis in NSCs. However, these changes were normalized by inhibiting the 
expression of AR with fidarestat, indicating that high glucose impairs the growth and 
survival of NSCs via oxidative stress caused by altered polyol metabolism. 
Interestingly, inhibition of AR could suppress the high glucose-induced oxidative 
stress only partially while it could restore the cell viability completely indicating that 
cell damage occurs only if oxidative stress level is beyond a certain threshold. 
2.3. High glucose alters the expression of Glut1 in NSCs 
(Moley et al., 1998b). In addition, congenital malformations that are similar to 
2.2. High glucose impairs the survival and proliferation of NSCs via oxidative 
stress 
Glut1 is an important glucose transporter expressed in the neural tube, heart, gut and 
optic vesicle in rat embryos during the early organogenesis period, and is responsible 
for supplying glucose as an embryonic fuel in these tissues (Matsumoto et al., 1995). 
Expression of Glut1 mRNA and protein was shown to be reduced in pre-implantation 
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diabetic embryopathy have been shown in Glut1 deficient mouse embryos (Heilig et 
al., 2003),  suggesting that altered Glut1 expression may be one of the causative 
factors for the malformations in embryos of diabetic pregnancy.  
ed at 24 hours and subsequently decreased at 72 hours of exposure in 
comparison to that in NSCs exposed to physiological glucose concentration.  It 
appears that the increased expression of Glut1 at the early stage is the direct effect of 
high extracellular glucose on NSCs, which may contribute to increased uptake of 
glucose and induction of oxidative stress in NSCs. The subsequent reduction of Glut1 
expression may be associated with oxidative stress since the reduction of the oxidative 
stress by the inhibitor of AR prevents the downregulation of Glut1 expression in 
NSCs exposed to HG. Hence it is suggested that the decrease in Glut1 expression 
during the later phase could play an important role in impairing the proliferation and 
viability of NSCs, leading to NTDs in embryos of diabetic pregnancy. On the other 
hand as described in other systems (Deckwerth et al., 1998; Li et al., 1998; Bialik et 
al., 1999; Chi et al., 2000), HG-induced downregulation of Glut1 expression and 
r triggering the premature 
In the present study, Glut1 expression in NSCs exposed to high glucose was 
increas
increase in ROS production in NSCs may be responsible fo
onset of apoptosis which may result in loss of key progenitor cells in NSCs and 
subsequently  NTDs in embryos of diabetic pregnancy. 
Collectively, high concentration of glucose in vitro alters the expression of 
genes that are involved in cell cycle progression and cell fate specification in NSCs, 
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glucose metabolism through polyol pathway by inducing the expression of aldose 
reductase, leading to intracellular metabolic disturbances and oxidative stress which 
could further contribute to altered expression of developmental control genes, thereby 
resulting in abnormal viability and proliferation of NSCs. These changes are believed 
to mimic the events that occur during the neurodevelopment in embryos of diabetic 
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Epidemiological studies and experiments in rodent embryos revealed that there is an 
increased risk for fetal malformations and spontaneous abortions in diabetic 
pregnancies (Hanson et al., 1990; Mills, 1982; Sakamaki et al., 1999). From human 
epidemiological studies, a direct correlati n between the degree of 
maternal hyperglycemia during the first trimester and the incidence and severity of 
fetal abnormalities (Miller et al., 1981). Maternal diabetes develops in 2-6% of total 
pregnancies, depending on geographical and ethnic background. In Asia, it accounts 
for 4-6% of total pregnancies (Kieffer et al., 1999; Lapolla et al., 2004; Moum et al., 
2004). About 10% of fetuses pregnancy display congenital 
malformations in various organ systems including cardiovascular, gastrointestinal, 
genitourinary and neurologica l., 1990; Mills et al., 1979), 
among which the neural tube defects (NTDs) such as anencephaly, holoprosencephaly 
and syntelencephaly were more frequently demonstrated (Eriksson, 1995; Kucera, 
1971; Robin et al., 1996). Recent studies by the Diabetes Control and Complications 
Trial Research Group show that tight control of blood glucose levels in diabetic 
mothers decreases the progression of a number of diabetic complications. However, it 
appears that the pre-existing tissue damage can not be reversed even after 
normoglycemic levels are achieved during pregnancy.  
In recent years, considerable efforts have been made to investigate the etiology 
of birth defects among infants of diabetic mothers (Evers et al., 2004; Cleves and 
Hobbs, 2004; Reece and Hobbins, 1986). It has been shown that diabetes-induced 
fetal abnormalities are accompanied by some metabolic disturbances including 
elevated superoxide dismutase (SOD) activity, reduced levels of myoinositol and 
on has been show
 from diabetic 
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arachidonic acid and inhibition of the pentose phosphate shunt pathway (Cederberg et 
al., 2000; Eriksson and Borg, 1991; Eriksson and Borg, 1993; Goldman et al., 1985; 
Shum and Sadler, 1990). Moreover, the frequency of fetal malformations in diabetic 
pregnancy has been reported to be markedly reduced by dietary supplements of 
antioxidants such as vitamin E or vitamin C and butylated hydroxytoluene (Chang et 
al., 2003; Eriksson and Borg, 1991; Eriksson and Siman, 1996; Siman and Eriksson, 
1997a; Siman and Eriksson, 1997b), suggesting that oxidative stress is involved in the 
etiology of fetal dysmorphogenesis.  
NSCs give rise to diverse types of neurons, astrocytes and oligodendrocytes 
that compose the nervous system. A complex orchestra
Furthermore, several experimental studies have shown that NTDs in embryos 
of diabetic mice are associated with altered expression of genes, which control 
development of the neural tube (Chang et al., 2003; Liao et al., 2004; Li et al., 2005; 
Loeken, 2005; Loeken, 2006). Since the neural tube development depends on the 
proliferation and lineage specification of NSCs which appear to be regulated by 
several maternal teratogens, the present study was aimed to investigate the response 
of NSCs to glucotoxicity caused by the high glucose environment. 
tion of stem cell specification, 
expansion and differentiation is required for the proper development of the neural 
tube. Hence, it was hypothesized that maternal diabetes alters the expression pattern 
of developmental control genes involved in proliferation, differentiation and lineage 
specification of NSCs leading to neural tube anomalies during embryogenesis. In 
order to address this, we have investigated the effect of high concentrations of glucose 
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involved in the growth, survival, proliferation and lineage specification of NSCs and 
their differentiated progeny cells isolated from the telencephalon of embryonic mice. 
In the present study, high glucose was found to impair the proliferation and 
survival of NSCs and differentiated cells in vitro. Moreover, the changes in 
proliferation and survival of NSCs exposed to high glucose were associated with 
increased expression of signaling molecules, Shh and Bmp4. It is possible that the 
high glucose-induced apoptosis and proliferation arrest in NSCs may be linked to the 
enhanced expression of Bmp4 as the proapoptotic and antiproliferative effects of 
Bmp4 o
e proper molecular 
and morphological orchestration of NSCs is required for the formation of the neural 
tube. 
n various cell types including ventricular zone progenitor cells have been well 
established (Glozak and Rogers, 2001; Gomes and Kessler, 2001; Israsena and 
Kessler, 2002). However, the increased expression of Shh in NSCs exposed to high 
glucose appeared to antagonize the high glucose-mediated apoptosis and promote the 
survival of the NSCs since Shh has been shown to promote the survival of 
neuroepithelial cells by inhibiting the apoptosis (Thibert et al., 2003). These changes 
in cell cycle progression could disturb the neurodevelopment as th
However in vivo, the proliferation index appeared to be increased in the 
ventral telencephalon and decreased in the dorsal telencephalon within the forebrain 
in embryos of diabetic pregnancy, indicating that glucose-responsive local factors 
could influence the proliferation efficiency. This is possible as the forebrain 
morphology is complex and the development of its dorsal and ventral telencephalic 
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factors which may exhibit differential response to the glucotoxicity. Overall, the 
disturbance in normal cycle of cell death and proliferation of neural precursor cells 
and their progenies in the developing neural tube by hyperglycemia may in turn 
contribute to the defective patterning and the subsequent complex neural tube 
anomalies in embryos of diabetic pregnancies. 
t study, the increased mRNA expression of Neurog1/2, Ascl1 and Olig1 in 
NSCs and/or differentiated cells exposed to high glucose could be due to enhanced 
expression of Shh, leading to increased neurogenesis and oligodendrocytes 
development. It is suggested that the enhanced Shh expression in the NSCs is the 
basis for the induced specification of neurons and oligodendrocytes in the high 
glucose medium. 
Besides leading to cell cycle arrest and apoptosis in NSCs, high concentration 
of glucose also alters the lineage specification of NSCs, increasing the neurogenesis 
and gliogenesis (including astrocytes and oligodendrocytes) in the early stage of 
differentiation. Determination of neuronal and glial cell fates from NSCs during 
neural tube development depends on signaling molecules such as Shh and BMPs and 
their downstream transcription factors such as bHLH factors (Vetter and Brown, 2001) 
and homeodomain factors (Jessell, 2000).  Several lines of evidence suggest that Shh 
activates the expression of members of bHLH factors such as Neurog1/2, Ascl1 and 
Olig1 (Alberta et al., 2001; Ota and Ito, 2003; Ross et al., 2003; Tekki-Kessaris et al., 
2001; Yung et al., 2002) which initiate neurogenesis and oligodendrocyte 
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On the other hand, two other bHLH factors, Hes1 and Hes5 which are 
regulated by the Notch/Delta signaling and inhibit neurogenesis by repressing 
proneural genes such as Ascl1 and neurogenins (Bertrand et al., 2002; Ohtsuka et al., 
1999), also responded to high concentration of glucose. The decreased mRNA 
expression of Dll1, a Notch ligand in the NSCs exposed to high glucose could have 
caused downregulation of its downstream gene Hes1, resulting in accelerated 
neuronal differentiation, possibly by the unopposed action of its target gene Ascl1. 
Moreover, Bmp4 has been shown to facilitate commitment of NSCs into astrocytes 
(Gomes et al., 2003; Liu et al., 2004), suggesting that the increased mRNA expression 
of GFAP and increased number of GFAP immuno-positive astrocytes amongst the 
differentiated cells from NSCs exposed to HG medium may be mediated by the  
enhanced expression of Bmp4. 
 
 
Collectively, high concentration of glucose alters the expression of genes that 
are involved in cell cycle progression and cell fate specification in the NSCs, leading 
to increased neuro- and glio-genesis (Illustration 2). These changes are believed to 
mimic the events that occur during the neurodevelopment in embryos of diabetic 
pregnancies, and may form the basis for defective neural tube patterning observed in 
these embryos, although the precise mechanisms by which the elevated glucose level 
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 It is possible that high glucose could induce intracellular metabolic 
disturbances which may in turn lead to the observed changes in gene expression. In 
ajor 
contributing factor to the altered gene expression, as simila has been 
demonstrated in the inner cell mass of high glucose-treated mouse blastocysts 
(L 2002) a ells exposed to high glucose (Zanetti et 
al., 2001). It is also possible that there could be a direct effect of high concentration of 
 expression of som es, as in the process involved in 
gulation of glucose-responsive genes in the β-cell or the liver. 
The present study clearly demo centration of glucose 
duces intracellular metabolic abnormalities in NSCs, leading to oxidative stress 
ereby resulting in alter cle progression of NSCs during neurodevelopment. 
ne of the mechanisms by which high glucose induced oxidative stress in many cell 
pes is the enhanced glu
rownlee, 2001). The present study further demonstrated that increased expression of 
ldose reductase (AR), which catalyzes reduction of glucose to sorbitol, induces 
xidative stress in NSCs exposed to high glucose.  In addition, it can not be exclude 
alities in NSCs of the embryos in in vivo conditions. 
The glucose related metabolic pathway in many cell types is regulated by the 
glucose transporter 1 (Glut1) which controls glucose uptake (Vannucci et al., 1997b; 
Vannucci et al., 1997a). In the present study, high concentration of glucose initially 
upregulated the expression of Glut1, which increased the glucose uptake in NSCs. 
addition, oxidative stress mediated by the glucotoxicity is considered to be the m
r mechanism 
eunda-Casi et al., nd in endothelial c
glucose on the e developmental gen
re
nstrated that the high con
in
th ed cell cy
O
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The ele
nd increase in ROS 
production in NSCs may be responsible for triggering the premature onset of 
apoptosis which may result in loss of key progenitor cells in NSCs and in turn this 
event may manifest as NTDs in embryos of diabetic pregnancy. 
vant to human in vivo 
pathophysiology, they provide some clues which may be further explored for better 
insights into the mechanisms underlying the pathogenesis of NTDs associated with 
diabetic pregnancy. 
vated intracellular glucose appears to increase the glucose reduction by altered 
polyol pathway and induce oxidative stress by increased ROS production in NSCs. 
Subsequently, the oxidative stress was found to be associated with downregulation of 
Glut1 expression in NSCs exposed to high glucose. Hence, it is suggested that the 
decrease in Glut1 expression during the later phase could reduce the glucose uptake 
and eventually impair the viability, proliferation, and lineage specification of NSCs, 
leading to NTDs in embryos of diabetic pregnancy. On the other hand, as described in 
other systems (Bialik et al., 1999; Chi et al., 2000; Deckwerth et al., 1998; Li et al., 
1998), high glucose-induced decrease in Glut1 expression a
In conclusion, high glucose alters the polyol pathway by inducing the 
expression of AR leading to intracellular metabolic disturbances and oxidative stress 
which further contribute to altered expression of developmental control genes 
including Glut1, thereby resulting in abnormal proliferation and cell fate specification 
of NSCs (Illustration 3). This could be the basis for abnormal patterning of neural 
tubes leading to NTDs in embryos of diabetic pregnancy. Although the in vitro results 
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Scope for the Future Study 
The present study has shown that high concentration of glucose decreases the 
prolife  High glucose has also been shown to 
upregulate the expression of some genes (Mash-1, Ngn1/2, Olig1/2 Bmp4, and Shh) 
involved in neurogenesis and gliogenesis (oligoden ) in NSCs. 
Based on these results, it is suggested that high glucose alters the lineage specification 
of NSCs by ch aling molecules and transcription 
ctors of various signaling pathways and this alteration forms the basis for neural 
be malformations in embryos of diabetic pregnancy. Since neurulation from NSCs 
 believed t  signaling molecules and 
anscription factors, global ge ion analysis using high density Affymetrix 
oligonucleotide microarray gene chips is required to identify differentially expressed 
genes in NSCs exposed to glucotoxicity. This global gene expression analysis would 
ncover m  that occur during 
eurodevelopment. ay provide new insights on how 
igh glucose/hyperglycemia influences major stem cell decisions that regulate the 
ze, shape and cellular diversity of the nervous system during development. 
The present study also demonstrated that high glucose induces oxidative stress 
 NSCs in a time and dose dependent manner. Induction of oxidative stress plays a 
tic pregnancy. It is 
ggested that induction of oxidative stress in NSCs exposed to high glucose is 
ssociated with intracellular metabolic abnormalities including altered polyol 
ration index, increases apoptosis in NSCs.
drocytes and astrocytes
anging the expression patterns of sign
fa
tu
is o be a complex process regulated by several
ne expresstr
u aternal diabetes-induced biological trends




central role in the pathogenesis of diabetic complications, including congenital 
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metabolic pathways, leading to altered expression of genes that are involved in cell 
cycle progression and cell fate specification of NSCs, thereby resulting in NTDs. 
Further investigation is required to understand the molecular mechanisms by which 
high glucose induces oxidative stress in NSCs, and to examine the expression pattern 
of genes of various signaling pathways disturbed by oxidative stress in NSCs exposed 
to high glucose. The candidate signaling pathways include pathways mediated by p38 
and JNK mitogen-activated protein kinases (MAPKs) and nuclear factor-κB (NF-κB) 
as they have been shown to play an important role on proliferation, migration and 
differentiation of NSCs. This would reveal possible therapeutic targets for the 
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Figure 1 a-b) Mouse embryos (E11.5) obtained from normal (a) and diabetic 
(b) pregnancy. The embryo from diabetic mouse exhibits an exencephaly 
extending from the forebrain to hindbrain (arrows). The black lines indicate 
the planes of section showed in (c) and (d). The same planes of section were 
also used in this study for immuostaining in Figure 11. c-d) The frontal 
sections of the forebrain at the level of eyes stained with Hematoxylin and 
Eosin display obvious morphological defects which include fusion and 
thickening of the ventral telencephalon (black arrows) and distortion of the 
dorsal telencephalon (red arrows) in the embryo from diabetic mouse (d) in 
comparison to that of control mouse (c). Scale bar: (a-b) 1mm, (c-d) 500µm. 

































Figure 2. Neural stem cells (NSCs) derived from the telencephalon of E13 
mouse embryo. a-c) NSCs were cultured in the serum-free medium containing 
epidermal growth factor (EGF) for 24 h (a), 48 h (b), and 72 h (c). NSCs grew 
into suspended neurospheres in 72h (c, arrow). d-f) Neurosphere was stained 
with Nestin by immunocytochemistry (d, red), and counterstained with DAPI 
(e, blue). Note that most of the cells in the neurosphere show Nestin 










































Figure 3. Differentiation of NSCs. a-c) NSCs were induced to differentiate 
(by withdrawal of EGF) for 24 h (a), 48 h (b), and 72 h (c). d-e) After 3 days 
of differentiation, NSCs gave rise to neurons (d-e, red, short arrows), 
astrocytes (d, green, long arrow), oligodendrocytes (e, green, long arrow) as 
demonstrated immunohistochemically using anti-ß-tubulin III, GFAP, and 






























































Figure 4. a) XTT assays revealed that the number of viable NSCs in both PG 
(unbroken line) and HG (dashed line) media was increased from day 1 to day 
3. (b) The relative increase of viable NSCs in HG (filled bar) medium was 
lower compared with those in PG medium (open bar). The relative increase 
shown was estimated from the relative ratio between day-3 absorbance and 













































































Figure 5. HG inhibits proliferation index of NSCs. BrdU-labelled cells in the 
neurospheres (a, b) appear in yellow as the BrdU (green) is colocalised with 
propidium iodide (red), a nuclear marker. Note the decreased number of 
BrdU-positive cells in the neurosphere exposed to HG (b). The percentage of 
BrdU-positive cells (c) in neurospheres exposed to HG medium (filled bar) 
was less in comparison with those in PG medium (open bar). The data are 



























































Figure 6. HG induces apoptotic cell death in NSCs. Apoptotic cells in NSCs 
(arrows in a, b) by TUNEL staining (green) are colocalised with propidium 
iodide (red).  The percentage of apoptotic cells was increased in NSCs 
exposed to HG in comparison to those in NSCs exposed to PG medium (c). 




























































Figure 7. Effects of HG on viability of differentiated cells from NSCs. a) 
XTT assays at day 1 and day 3 of differentiation. PG, unbroken line; HG, 
dotted line. (b) The relative increase of viable cells, which is expressed by the 
ratio of day-3 absorbance in relation to day-1 absorbance, in HG medium 
(filled bar) was the same as those in PG medium (open bar). The data are 







































































Figure 8. Effects of HG on proliferation of differentiated cells from NSCs. a-
b) Confocal images show the colocalisation of BrdU-labelled (red) 
differentiated cells with MAP2 (green). Only a few BrdU-positive 
differentiated cells are seen in PG medium (a, arrows) and HG medium (b, 
arrows). Quantitative analysis demonstrates that the proliferation index (c) 
was significantly decreased in differentiated cells exposed to HG (filled bar) 
in comparison to those exposed to PG medium (open bar). The data are 




























































Figure 9. TUNEL analysis to show the effect of HG on apoptosis of 
differentiated cells from NSCs. Quantitative analysis demonstrates that there is 
no significant difference in the incidence of apoptotic cell death between the 
differentiated cells in HG medium (filled bar) and that in PG medium (open 








































Figure 10. HG promotes neuronal and glial differentiation of NSCs. 
Neurospheres grown for 3 days were induced to differentiate in PG (a, c, e) or 
HG (b, d, f) medium. At day 3 of differentiation, cells exhibit 
immunoreactivity for MAP2, the neuronal marker (a, b arrows, green), NG2, 
the oligodendrocyte marker (c, d arrows, green), and GFAP, the astrocyte 
marker (e, f arrows, green). The cells are counterstained with DAPI (blue). g) 
The percentages of MAP2-, NG2- and GFAP-positive cells were increased in 
differentiated cells in HG medium (filled bars) compared with PG medium 
(open bars). (h) Results of real-time RT-PCR demonstrate that mRNA 
expression levels of MAP2, GFAP, and NG2 were significantly increased, 
while mRNA expression level of Nestin was significantly decreased, in 
differentiated cells exposed to HG medium (filled bars) compared with that in 
PG medium (open bars). The data are presented as Means ± SD (n=5). 


















































































































Figure 11. Frontal sections show BrdU and MAP2 staining in the forebrain of 
embryos (E11.5) from control (a, b, c) and diabetic (d, e, f) mice. Sections are 
counterstained with DAPI (blue). Compared with controls (a, b), the number 
of BrdU-positive proliferating cells (red) in the dorsal telencephalon of 
embryo from diabetic mice (d, e) appears to be decreased. However, in the 
ventral telencephalon, the number of BrdU-positive cells appears to be 
increased in embryos of diabetic mice (d, f) compared with that in normal 
mice (a, c). In addition, there are more MAP2-positive neurons (green) in the 
telencephalon of embryos from diabetic mice (e, f arrowheads) in comparison 
with that of controls (b, c arrowheads). Quantitative analysis revealed that the 
percentage of BrdU-positive cells was significantly decreased in the dorsal 
telencephalon (b, e arrows; g), increased in the ventral telencephalon (c, f 
arrows; g), and totally decreased in the whole telencephalon of embryos from 
diabetic mice (g, filled bars) compared with that of controls (g, open bars). 
The data are presented as Mean ± SD (n=3). *p<0.05, **p<0.01. Scale bar: a, 
d: 500 µm; b, c, e, f: 100 µm. dt, dorsal telencephalon; e, eye; lv, lateral 












































































Figure 12. a-e) A 243bp fragment of Shh mRNA was amplified by the real 
time RT-PCR in NSCs and differentiated cells (a), and the specificity of the 
amplification was confirmed by the melting curve (b). The expression of Shh 
mRNA in cells after 1-, 2-, and 3-day of differentiation from NSCs was 
increased significantly, compared to the mRNA level in NSCs (c). The mRNA 
expression level of Shh was significantly increased in NSCs (d) and 
differentiated cells (e) exposed to the HG medium (filled bars), compared with 
those cultured in the PG medium (open bars). f-i) The mRNA expression of 
Shh was localized in NSCs (f, g, arrows) and differentiated cells (h, i, arrows) 
by in situ hybridization. The intensity of Shh mRNA expression appears to be 
stronger in NSCs exposed to the HG medium (g) than those in the PG medium 
(f). More differentiated cells (i) show mRNA expression of Shh in culture 
exposed to the HG medium than those exposed to the PG medium (h). The 
data are presented as Mean ± SD (n=5); *p<0.01. M, DNA size marker; ns-3d, 
neural stem cells after 3 days of growth; dc-1d, dc-2d, dc-3d, cells after 1-, 2-, 
or 3-day of differentiation. NSC, neural stem cell; DC, differentiated cells. 



































































































































Figure 13. a-d) A 190bp fragment of Bmp4 mRNA was amplified by the real 
time RT-PCR in NSCs and differentiated cells (a), and the specificity of 
amplification was confirmed by the melting curve (b). The mRNA expression 
levels of Bmp4 in cells after 1-, 2-, and 3-day of differentiation from NSCs 
were significantly higher than that in NSCs (c). In NSCs exposed to the HG 
medium (filled bar), the mRNA expression level of Bmp4 was significantly 
increased in comparison with NSCs cultured in the PG medium (open bar) 
(d). e-h) The mRNA expression of Bmp4 was localized in NSCs (e, f, arrows) 
and differentiated cells (g, h, arrows) by in situ hybridization. The staining 
intensity of Bmp4 mRNA expression both in NSCs (e, f) and differentiated 
cells (g, h) exposed to PG and HG medium appears weak. No difference in 
staining intensity is detectable between cultures exposed to the PG and HG 
medium. The data are presented as Mean ± SD (n=5); *p<0.01. M, DNA size 
marker. ns-3d, neural stem cells after 3 days of growth; dc-1d, dc-2d, dc-3d, 
cells after 1-, 2-, or 3-day of differentiation. NSC, neural stem cell; DC, 

































































































Figure 14. a-e) The mRNA of Dll1 (245bp) was amplified (a) in NSCs and in 
cells after 1-, 2-, and 3-days of differentiation from NSCs by the real time RT-
PCR, and the specificity of the amplification was confirmed by the melting 
curve (b). The expression of Dll1 was increased in cells after 1-day of 
differentiaton from NSCs, compared to that in NSCs (c)., The mRNA 
expression level of Dll1 was significantly decreased in NSCs exposed to the 
HG medium (d, filled bar)in comparison with NSCs cultured in the PG 
medium (d, open bar). In differentiated cells exposed to the HG medium (e, 
filled bar), the mRNA level of Dll1 was significantly increased, compared 
with the expression in those exposed the PG medium (e, open bar). f-i) The 
expression of Dll1 protein was localized to the NSCs (f, g, arrows) and 
differentiated cells (h, i, arrows) by immunocytochemistry. The number of 
Dll1-positive cells appears less in NSCs exposed to the HG medium (g) than 
in NSCs exposed to the PG medium (f). In contrast, there are more number of 
Dll1- positive cells in the culture of differentiated cells exposed to the HG 
medium (i) in comparison to those in the PG medium (h). The data are 
presented as Mean ± SD (n=5); *p<0.01. M, DNA size marker. ns-3d, neural 
stem cells after 3 days of growth; dc-1d, dc-2d, dc-3d, cells after 1-, 2-, or 3-




































































































































Figure 15. A 377bp fragment of Hes1 mRNA was amplified by real time RT-
PCR in NSCs and differentiated cells (a), and the specificity of the 
amplification was confirmed by the melting curve (b). The expression of Hes1 
was downregulated in cells after 1, 2, and 3- day of differentiation from NSCs 
in comparison to that in NSCs (c). The mRNA expression levels of Hes1 in 
NSCs exposed to the HG medium (d, filled bar), was significantly decreased 
in comparison with that in NSCs exposed to the PG medium (d, open bar). 
The data are presented as Mean ± SD; (n=5).  *p<0.01. M, DNA size marker. 
ns-3d, neural stem cells after 3 days of growth; dc-1d, dc-2d, dc-3d, cells after 























































































Figure 16. a-d) A 354bp fragment of Hes5 mRNA was amplified by real time 
RT-PCR in NSCs and differentiated cells (a), and the specificity of the 
amplification was confirmed by the melting curve (b). The mRNA expression 
of Hes5 was upregulated in cells after 1 day of differentiation compared to that 
in NSCs (c). The mRNA expression level of Hes5 in the differentiated cells 
exposed to the HG medium (d, filled bar), has been shown to be significantly 
increased, compared with the expression in those exposed to the PG medium 
(d, open bar). e-h) The expression of Hes5 protein was localized to the NSCs 
(e, f, arrows) and differentiated cells (g, h, arrows) by immunocytochemistry. 
It appears that there is no difference in the number of Hes5-positive cells 
between cultures of NSCs exposed to the PG and HG medium (e, f). In 
contrast, there seems to be more number of Hes5- positive cells in culture of 
differentiated cells exposed to the HG medium (h) than those in the PG 
medium (g). The data are presented as Mean ± SD (n=5); *p<0.01. M, DNA 
size marker. ns-3d, neural stem cells after 3 days of growth; dc-1d, dc-2d, dc-
3d, cells after 1-, 2-, or 3-day of differentiation. NSC, neural stem cell; DC, 






































































































Figure 17. a-e) The mRNA expression levels of Neurog1 (239bp) in NSCs 
and in cells after 1-, 2-, and 3-days of differentiation from NSCs were 
analyzed by the real time RT-PCR (a), and the specificity of the amplification 
was confirmed by the melting curve (b). The mRNA expression of Neurog1 in 
differentiated cells was upregulated after 1 day and 2-days of differentiation 
(c). The mRNA expression level of Neurog1 in NSCs exposed to the HG 
medium (d, filled bar), was significantly upregulated in comparison with that 
in NSCs exposed to PG medium (d, open bar). Similarly, the mRNA 
expression level of Neurog1 was significantly increased in differentiated cells 
exposed to the HG medium (e, filled bar), in comparison to the expression in 
those exposed to the PG medium (e, open bar). f-i) The mRNA localization of 
Neurog1 in NSCs (f, g, arrows) and differentiated cells (h, i, arrows) was 
detected by in situ hybridization. The intensity of Neurog1 mRNA expression 
appears to be stronger in differentiated cells (h, i) than in NSCs (f, g).  In 
addition, more number of differentiated cells exposed to the HG medium (i) 
appears to exhibit mRNA expression of Neurog1 than those in the PG medium 
(h). The data are presented as Mean ± SD (n=5). *p<0.05, **p<0.01. M, DNA 
size marker. ns-3d, neural stem cells after 3 days of growth; dc-1d, dc-2d, dc-
3d, cells after 1-, 2-, or 3-day of differentiation. NSC, neural stem cell; DC, 












































































































































Figure 18. a-e) The mRNA expression levels of Neurog2 (237bp) in NSCs 
and in cells after 1-, 2-, and 3-days of differentiation from NSCs were 
analyzed by the real time RT-PCR (a), and the specificity of the amplification 
was confirmed by the melting curve (b). The mRNA expression levels of 
Neurog2 were significantly increased in cells after 1, 2, 3 days of 
differentiation than in NSCs (c). The mRNA expression level of Neurog2 was 
significantly upregulated in NSCs and differentiated cells exposed to the HG 
medium (d, e, filled bar) in comparison with the expression in those exposed 
to the PG medium (d, e, open bar). f-i) The mRNA localization of Neurog2 in 
NSCs (f, g, arrows) and differentiated cells (h, i, arrows) was detected by in 
situ hybridization. More number of cells appears to exhibit Neurog2 mRNA 
expression in cultures of NSCs as well as differentiated cells exposed to the 
HG medium (g, i) than in those exposed to the PG medium (f, h). The data are 
presented as Mean ± SD (n=5). *p<0.05, **p<0.01. M, DNA size marker. ns-
3d, neural stem cells after 3 days of growth; dc-1d, dc-2d, dc-3d, cells after 1-, 
2-, or 3-day of differentiation. NSC, neural stem cell; DC, differentiated cells. 














































































































































Figure 19. a-d) The mRNA expression of Ascl1 (482bp) in NSCs and in cells 
after 1-, 2-, and 3-days of differentiation from NSCs was analyzed by the real 
time RT-PCR (a), and the specificity of the amplification was confirmed by 
the melting curve (b). The mRNA expression of Ascl1 was decreased in 
differentiated cells after 3 days of culture, compared with that in NSCs (c). 
The mRNA expression level of Ascl1 was significantly upregulated in NSCs 
exposed to the HG medium (d, filled bar) in comparison with the expression 
in those exposed to the PG medium (d, open bar). e-h) The mRNA 
localization of Ascl1 in NSCs (e, f, arrows) and differentiated cells (g, h, 
arrows) was detected by in situ hybridization. The intensity of Ascl1 mRNA 
expression appears to be stronger in NSCs exposed to the HG medium (f) than 
in those exposed to the PG medium (e). However, the mRNA expression 
appears to be unaltered in differentiated cells exposed to HG medium (g, h).  
The data are presented as Mean ± SD (n=5). *p<0.05. M, DNA size marker. 
ns-3d, neural stem cells after 3 days of growth; dc-1d, dc-2d, dc-3d, cells after 
1-, 2-, or 3-day of differentiation. NSC, neural stem cell; DC, differentiated 

































































































Figure 20. a-d) The mRNA expression levels of Olig1 (214bp) in NSCs and 
in cells after 1-, 2-, and 3-days of differentiation from NSCs were analyzed by 
the real time RT-PCR (a), and the specificity of the amplification was 
confirmed by the melting curve (b). The expression of Olig1 mRNA was 
significantly increased in cells 1-day after differentiation in comparison with 
the expression in NSCs (c). The mRNA expression level of Olig1 was 
significantly upregulated in NSCs exposed to the HG medium (d, filled bar) in 
comparison with that in the PG medium (d, open bar). e-h) The mRNA 
expression of Olig1 in NSCs (e, f, arrows) and differentiated cells (g, h, 
arrows) was detected by in situ hybridization. The intensity of Olig1 mRNA 
expression appears to be stronger in NSCs exposed to the HG medium (f) than 
in those exposed to the PG medium (e). However, mRNA expression level of 
Olig1 in differentiated cells appears to be unaltered by HG (g, h). The data are 
presented as Mean ± SD (n=5). *p<0.05, **p<0.01. M, DNA size marker. ns-
3d, neural stem cells after 3 days of growth; dc-1d, dc-2d, dc-3d, cells after 1-, 
2-, or 3-day of differentiation. NSC, neural stem cell; DC, differentiated cells. 


























































































Figure 21. a-c) The mRNA expression levels of Olig2 (232bp) in NSCs and in 
cells after 1-, 2-, and 3-days of differentiation from NSCs were analyzed by 
the real time RT-PCR (a), and the specificity of the amplification was 
confirmed by the melting curve (b). The mRNA level of Olig2 was 
upregulated in cells after 1 day and 2 days of differentiation, in comparison to 
that in NSCs (c). d-g) The mRNA expression of Olig2 in NSCs (d, e, arrows) 
and differentiated cells (f, g, arrows) was detected by in situ hybridization. 
There seems to be no difference in the intensity of Olig2 mRNA expression in 
NSCs and differentiated cells exposed to the HG and PG medium. The data 
are presented as Mean ± SD (n=5). *p<0.05. M, DNA size marker. ns-3d, 
neural stem cells after 3 days of growth; dc-1d, dc-2d, dc-3d, cells after 1-, 2-, 
or 3-day of differentiation. NSC, neural stem cell; DC, differentiated cells. 





































































Figure 22. Intracellular ROS in NSCs exposed to PG (5mmmol/l) for 72h or 
HG (30 or 45mmol/l) medium for 24h or 72h. (a) ROS was detected by flow 
cytometry using CM-H2DCFDA as the probe. The histograms shown represent 
the mean fluorescence intensity (X axis) in number of cells (Y axis). P: the 
percentage of cells that exhibit the fluorescence intensities in the range set by 
marker 1. (b) The fold changes in the amount of ROS production in NSCs 
exposed to HG medium are presented as the relative fluorescence intensity, 
compared to the fluorescence intensity in NSCs exposed to PG medium. The 
ROS production was significantly increased in NSCs exposed to 30mmol/l of 
glucose for 72h (1.40 ± 0.02 folds) and 45mmol/l of glucose for 24h (1.05 ± 
0.02 folds) and 72h (1.77 ± 0.03 folds), compared to that in NSCs exposed to 
PG medium. NSCs exposed to 45mmol/l of glucose for 72h produced more 
ROS than those in 30mmol/l of glucose for 72h (1.77 ± 0.03 vs 1.40 ± 0.03 


























































5 mmol/l       P=50.59%, X=324.28 
30 mmol/l-24 h    P=53.97%, X=336.92 
30 mmol/l-72 h    P=75.28%, X=454.19 
45 mmol/l-24 h    P=54.93%, X=339.00 












Figure 23. Aldose reductase mRNA (232bp) was amplified in NSCs as shown 
(a), and specificity of the amplification was confirmed by the melting curve 
(b). The expression level of AR in NSCs was quantified by the real time RT-
PCR (c). NSCs exposed to 30mmol/l glucose for 72 h showed significantly 
increased AR mRNA expression level, compared to that in NSCs exposed to 
PG medium for 72 h (1.21 ± 0.03 vs 1.01 ± 0.14 folds,). M, DNA molecular 



























































Figure 24. ROS production in NSCs exposed to PG or HG (30mmol/l) 
medium with or without 1µmol/l of fidarestat for 72h was measured using 
CM-H2DCFDA as the probe by flow cytometry. Addition of fidarestat 
attenuated the production of ROS in NSCs exposed to HG medium for 72h by 
47.4% (1.42 ± 0.03 vs 1.22 ± 0.01 folds). The data are presented as Mean ± 
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Figure 25. Glut1 mRNA (188bp) was amplified in NSCs as shown (a) and 
specificity of the amplification was confirmed by the melting curve (b). The 
expression levels of Glut1 in NSCs exposed to PG medium for 72h or HG 
(30mmol/l) medium for 24h or 72h were quantified by the real time RT-PCR 
(c). The mRNA level of Glut1 in NSCs exposed to HG for 24h was 
significantly higher than that in NSCs exposed to PG (1.26 ± 0.08 vs 1.03 ± 
0.09 folds). However, Glut1 mRNA appears to be downregulated in NSCs 
exposed to HG medium for 72h compared to that in NSCs exposed to PG 
medium (0.76 ± 0.05 vs 1.03 ± 0.09 folds). The data are presented as Mean ± 






















































Figure 26. The Glut1 protein expression in NSCs was analyzed by Western 
blot (a).β-actin was also detected as the internal control. b) The quantity of 
Glut1 protein in NSCs exposed to HG (30mmol/l) medium was found to be 
significantly increased in 24h and became downregulated in 72h  compared to 
that in NSCs exposed to PG medium. Exposure of NSCs to fidarestat together 
with HG for 72h attenuated this downregulation when compared to that in 
NSCs exposed to HG without fidarestat. The data are presented as Mean ± SD 
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Figure 27. a-c) Immunohistochemically, Glut1 protein expression (green) in 
NSCs was colocalized with Nestin (red), a pan-NSC marker. Seemingly 
increased expression of Glut1 in NSCs exposed to HG (30mmol/l) medium for 
24 h and subsequent downregulation of Glut1 expression in NSCs exposed to 
HG medium for 72h are evident (d-f). Fidarestat appears to inhibit the 
downregulation of Glut 1 protein expression in NSCs exposed to HG medium 
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Figure 28. (a) The viability of NSCs exposed to PG and HG (30mmol/l) 
medium with or without 1µmol/l of fidarestat for 24, 48 or 72h was examined 
by MTS assay. The absorbance at 490nm is directly proportional to the 
number of NSCs in each well at each time point. (b) The relative increase in 
the number of NSCs in each group is represented by the ratio of 72h viability 
to 24h viability. The relative increase of NSCs exposed to HG medium was 
less than that of NSCs exposed to PG medium. However, the relative increase 
in the number of NSCs exposed to HG medium with fidarestat was higher, 
compared to NSCs exposed to HG medium without fidarestat. The data are 

























































































Figure 29. Apoptosis in NSCs exposed to PG and HG (30mmol/l) medium for 
72h with or without fidarestat was analyzed by TUNEL (a-d, arrows). e) The 
percentage of TUNEL-positive cells in NSCs exposed to HG medium was 
higher than that in NSCs exposed to PG medium. Addition of 1µmol/l of 
fidarestat significantly decreased the percentage of apoptotic cells in NSCs 
exposed to HG medium. The data are presented as Mean ± SD (n=5). *p<0.01. 
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Figure 30. Cell proliferation index by BrdU labeling in NSCs exposed to PG 
and HG (30mmol/l) with or without fidarestat (a-d, arrows) for 72h. The 
percentage of proliferating cells appeared to be decreased in NSCs exposed to 
HG medium for 72h in comparison to that of NSCs exposed to PG medium for 
72h (a, b, e). Addition of fidarestat increased the proliferation index of NSCs 
exposed to the HG medium in comparison to that of NSCs exposed to the HG 
medium without fidarestat (c-e). The data are presented as Mean ± SD (n=5). 
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1. Solutions and buffers 
0.01M sodium citrate buffer: 
Deionised water 100ml 
Sodium citrate  2.94g 
The pH was adjusted to 4.5 by adding 0.01mol/l citrate acid. 
 
0.1M phosphate buffer (pH7.4): 
 NaH2PO4.H2O  2.76g 
 Na2HPO4.2H2O  14.24g 
Add deionized H2O up to 1 liter. The pH was adjusted to 7.4 by adding 1N 
hydrochloric acid (HCl) solution. 
 
4% paraformaldehyde (PF): 
Paraformaldehyde (Sigma)  4g 
0.1M phosphate buffer (pH 7.4) 100ml 
 
0.1M phosphate-buffer with 20% sucrose: 
 Sucrose     20g 
 0.1M phosphate buffer (pH 7.4) 100ml 
 
0.1M phosphate-buffered saline (PBS): 
Di-sodium hydrogen phosphate heptahydrate 13.3g 






Distilled water to make up to    1000ml 
The pH was adjusted to 7.4 by adding 1N hydrochloric acid (HCl) solution. 
 
1.5% gelatin solution: 
Gelatin   7.5g 
Chrome Alum  0.75g 
Distilled water  500ml 
 
1mM fidarestat stock solution:  
Fidarestat (Sanwa Kagaku Kenkyusho, Japan)  2.8mg 
Deionised water                        10ml 
The solution was mixed thoroughly and filtered through a 0.2µm filter. 
 
0.1M PBS containing 0.1% Triton-X 100 (PBS-TX): 
Triton-X 100   1ml 
0.1M PBS   999ml 
 
TFB1 solution:  
RbCl2    1.2g 
MnCl2.4H2O   0.99g 
CaCl2    0.15g 
Glycerol   15.0g 






The pH was adjusted to 5.8 by glacial acetic acid. The solution was made up 
to 100 ml with sterilized water. 
 
TFB2 solution:  
0.5M MOPS    2ml 
RbCl2     0.12g 
CaCl2.2H2O    1.1g 
Glycerol    15.0 g 
The pH was adjusted to 6.8 with NaOH. It was made up to 100ml with 
sterilized water. 
 
Luria-Bertani (LB) medium: 
Trypton    10g 
Yeast extract    5g 
NaCl     10g 
H2O     1000ml 
LB medium was purchased from the NUMI store of the National University of 
Singapore. 
 
DEPC treated Water: 
H2O     1000ml 
DEPC     100µl 







20X saline sodium citrate buffer (SSC): 
NaCl     87.6g 
NaCitrate    44.1g 
DEPC-H2O was added up to 500ml and pH was adjusted to 4.5 using 2N HCl.  
 
0.1M phosphate buffered saline with 0.2% BSA and 0.1% Triton X-100 (PBT): 
0.1M PBS    100ml 
Bovine serum albumin (BSA) 0.2g 
Triton X-100    0.1ml 
Stirred to mix thoroughly 
 
10X Denhardt’s solution: 
Bovine serum albumin (BSA) 200mg 
Polyvinylpyrrolidone   200mg 
Ficoll 400    200mg 
DEPC water was added up to 100ml. 
 
Hybridization buffer: 
Formamide     50ml 
20x SSC    25ml 
Yeast tRNA     50mg 






10x Denhardt’s solution  10ml 
Tween 20    0.1ml 
0.5M EDTA    1ml 
DEPC water was added up to 100ml. 
 
Alkaline phosphatase (AP) buffer: 
1M Tris, pH9.5   1ml 
 1M MgCl2    0.5ml 
 5M NaCl    0.2ml 
 Tween 20    10µl 
 125mM levamisole   40µl 
 DEPC water was added up to 10ml. 
 
10% resolving gel: 
 H2O     7.9ml 
 30% acrylamide mix   6.7ml 
1.5 M Tris (pH 8.8)   5.0ml 
 10% SDS    0.2ml 
 10% ammonium persulfate  0.2ml 
 TEMED    0.008ml 
 
5% stacking gel: 






 30% acrylamide mix   1.3ml 
1.0 M Tris (pH 6.8)   1.0ml 
 10% SDS    0.08ml 
 10% ammonium persulfate  0.08ml 
 TEMED    0.008ml 
 
1x SDS gel-loading buffer: 
 50mM Tris.Cl (pH 6.8) 
 100mM dithiothreitol 
 2% SDS 
 0.1% bromophenol blue 
 10% glycerol 
 
Tris-glycine electrophoresis buffer: 
 25mM Tris 
 250mM glycine 




 250mM glycine 








 Tris base    2.42 g 
 NaCl     0.8 g 
 Add H2O up to 1 liter; adjusted to pH 7.6 with 2N HCl 
 
1X TBST: 
 1X TBS 1 liter 








Chemicals Cat. No. Sources 
0.01% poly-L-ornithine solution P4957 Sigma-Aldrich, USA 
4’, 6- diamidino-2-phenylindole 
dihydrochloride (DAPI) 
D1306 Molecular Probes, USA 
5-bromo-2-deoxyuridine (BrdU) B5002 Sigma-Aldrich, USA 
Antibiotic antimycotic solution A5955 Sigma-Aldrich, USA 
Anti-digoxygenin-AP, Fab fragments 1093274 
Roche Applied Science, 
Germany 
CellTiter 96 Aqueous One Solution 
Cell Proliferation Assay kit 
G3580 Promega, USA 
CM-H2DCFDA C6827 Molecular Probes, USA 
DIG RNA labeling mix 1277073 
Roche Applied Science, 
Germany 
dNTP mix U1240 Promega, USA 
Dulbecco's Modified Eagle Medium 
(DMEM) 
11966025 Invitrogen,USA 
Epidermal Growth Factor (EGF E 4127 Sigma-Aldrich, USA 
F-12 Nutrient Mixture (F12) 31765035 Invitrogen,USA 










Fluorescent Mounting Medium S3023 Dako, USA 
In situ cell death detection kit 11684795910 





LightCycler FastStart DNA 
MasterPLUS SYBR Green I 
03515885001 
Roche Applied Sciences, 
Germany 
Mammalian protein extraction reagent 78503 Pierce, USA 
Molony murine leukemia virus 
reverse transcriptase (M-MLV) 
M1701 Promega, USA 
Mouse Ig blocking reagent PK2200 Vector Laboratories, USA 
NBT/BCIP 1681451 
Roche Applied Science, 
Germany 
Oligo(dT) primer C1101 Promega, USA 
Plasmid mini kit 12123 Qiagen, Germany 
Plasmid midi kit 12143 Qiagen, Germany 
Protease inhibitor cocktail kit 78410 Pierce, USA 






Chemicals Cat. No. Sources 
Propidium iodide (PI) P4170 Sigma-Aldrich, USA 
RNase inhibitor N2111 Promega, USA 
RNeasy mini kit 74106 Qiagen, Germany 
Sp6 RNA polymerase M0207S 
New England Biolabs, 
USA 
Streptozotocin (STZ) S0130 Sigma-Aldrich, USA 
T3 / T7 RNA polymerase 600111/600123 Stratagene, USA 
Trypsin and EDTA 15400-054 Invitrogen,USA 
XTT cell proliferation kit 1465015 











Antibodies Clone Cat. No. Source 
IHC WB 




Rabbit anti-MAP2 polyclonal AB5622 Chemicon, USA 500  
Mouse anti-tubulin, 
beta III isoform 
monoclonal AB1637 Chemicon, USA 500  
Rabbit anti- NG2 polyclonal AB5320 Chemicon, USA 300  
Rabbit anti- GFAP polyclonal AB5804 Chemicon, USA 1000  
Mouse anti-Nestin monoclonal MAB353 Chemicon, USA 500  
Rabbit anti-Delta 1 polyclonal ab10554 Abcam, UK 100  
Rabbit anti-Hes5 polyclonal AB5708 Chemicon, USA 200  
Rabbit anti- Glut 1 polyclonal AB 1340 Chemicon, USA 500 1000 






 AP124F Chemicon, USA 200  
Goat anti-mouse 
IgG, Cy3-linked 








 AP307C Chemicon, USA 200  
Goat anti-mouse 
IgG, HRP-linked 







IHC: immunohistochemistry, WB: western blotting 
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